Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

DPhil in Cancer Science

Students at a bench pipetting

The DPhil in Cancer Science Programme at the University of Oxford provides research-based doctoral training for cancer researchers from clinical, biological, engineering, mathematics and statistics backgrounds. 

Successful applicants receive a world-leading research training experience that integrates an education initiative spanning cancer patient care, tumour biology and research impact; on- course and post-programme mentorship; and a specialised, fundamental, subject-specific training programme that is tailored to individual research needs. 

Find out more about the course below, read about what our current students are up to, or find out what our alumni have gone on to achieve in their career as a cancer researcher. 

Applications are now closed

  • Eligibility
  • How to apply
  • DPhil Project Booklet
  • Supervisors

The Cancer Research UK Oxford Centre awards around  15 full-time positions on the DPhil in Cancer S cience Programme  each year for researchers looking to start their academic career at one of the world’s leading research organisations.

The programme is unique and distinctive in offering integrated training across the following themes: Immuno-Oncology; Cancer Big Data; Novel Therapeutics; Early Cancer Detection. It builds on Oxford’s outstanding research record in these areas, spanning both the University and Hospital Trust.

Students participating in the scheme will be offered:

  • a choice of interdisciplinary cutting-edge cancer research projects (see the Project Book tab for examples of the type of projects offered).
  • the ability to gain a working in-depth knowledge of the fundamentals of cancer biology and cancer patient care through advanced level seminars.
  • a world-renowned research environment that encourages the student’s originality and creativity in their research.
  • opportunities to develop skills in making and testing hypotheses, in developing new theories, and in planning and conducting experiments.
  • an environment in which to develop skills in written work, oral presentation and publishing the results of their research in high-profile scientific journals, through constructive feedback of written work and oral presentations.

At the end of the course, programme students will:

  • have gained a thorough knowledge of the basic principles of cancer research including the relevant literature and a comprehensive understanding of scientific methods and techniques applicable to their own research.
  • be able to demonstrate originality in the application of knowledge, together with a practical understanding of how research and enquiry are used to create and interpret knowledge in their field.
  • have the ability to critically evaluate current research and research techniques and methodologies.
  • be able to act autonomously in the planning and implementation of research.
  • be prepared for a career in cancer research.

The scheme caters to researchers from a wide range of backgrounds. There are four types of application welcomed as described below.

  • Application Type 1 – Clinical Trainees.  Qualified doctors at all stages of training (from foundation to higher specialist training).
  • Application Type 2 – Medical Undergraduates.  Medical students who are currently undertaking a primary medical qualification (MBBS, MBChB or equivalent). At entry, we will be looking for evidence of completion of at least the first two years of a primary medical qualification and achievement at the level of an upper-second or first-class honours degrees (or iBSc).
  • Application Type 3 – Non-Clinical/Fundamental Scientist.  Science graduates that hold (or be predicted to achieve) the equivalent of a first-class or strong upper second-class undergraduate degree with honours in biological, medical, or chemical science, as appropriate for the projects offered.
  • Application Type 4 – Non-Clinical/Fundamental Scientist.   Science graduates that hold (or be predicted to achieve) the equivalent of a first-class or strong upper second-class undergraduate degree with honours in engineering, mathematical/data,  or  physical science, as appropriate for the projects offered. 

More information can be found on the University of Oxford’s programme page  under the 'How to apply' section.

All offered places are fully funded at the home rate. This includes salary/stipend, University and College fees, and a research consumables budget of £13k p.a.. Salary and stipend provisions are summarised below:

  • Track 1 – 3 years of salary at Grade E63 or E64 Clinical Researcher.
  • Track 2 – 3 years of stipend at the rate of £21,000 per annum.
  • Track 3 – 4 years of stipend at the rate of £21,000 per annum.
  • Track 4 – 4 years of stipend at the rate of £21,000 per annum.

Applications from international candidates will be accepted, however funding at the home level is only available for this programme and therefore international applicants would need to either source further funding or support themselves financially for the remaining fees. If you are a prospective applicant from the EU, please refer to the following pages on fees and funding .

Your Application

The full application guide and link to start your application can be found here  under the 'How to apply' section.

Interviews are offered to the top-ranked applications, with the results being announced shortly afterwards. All applicants will be judged on the following;

  • Evidence of a prior interest in the area of research proposed is likely to advantage your application.
  • Prior publications are not required, but research experience and a track record demonstrating an interest in research may be an advantage.
  • It would be expected that graduate applicants would be familiar with the recent published work of their proposed supervisor.
  • Commitment to and passion for a career in cancer research.
  • Reasoning ability and academic curiosity.

If you are thinking of applying to the scheme, useful advice can be found  here . If you have any further questions about the programme or the application, please email [email protected] .

The pre-recorded videos for previous open days can be found below. 

If you have any questions about the DPhil in Cancer Science or applications, you can contact us on  [email protected]  and we will direct your question to the most appropriate person.

Prof Mark Middleton - Introduction to the DPhil in Cancer Science & the CRUK Oxford Centre

Prof Rob Gilbert - Cancer Research Training in Oxford

Dr Catherine Swales - Incorporating a DPhil into your undergraduate medical studies

Prof Chris Pugh - Incorporating a DPhil into your postgraduate clinical training

Applications to the DPhil in Cancer Science programme are now closed. Full project details of the 2024 round can be found in the linked project book below. 

  • Project Book 2024

Project submissions currently closed

For the DPhil in Cancer Science, we look for project submissions from PIs from across medical, physical, engineering and mathematical sciences. We typically advertise 40-50 projects to prospective students, who can apply for their preferred projects (examples of previous projects can be found in the Project Booklet tab).

The deadline for 2024 project submissions has now closed .

If you are interested in hosting a DPhil in Cancer Science student in 2025 and would like more information please  contact u s .

CRUK Oxford Centre Logo

DPhil students in the Cancer Science Programme at the University of Oxford are supported by a grant from Cancer Research UK, managed through the CRUK Oxford Centre .

SIGN UP TO OUR MAILING LIST

Prospective students can sign up to our mailing list to receive update and news on our DPhil opportunities.

CURRENT STUDENTS

Find out what our current students are up to as part of their DPhil in Cancer Science projects

Latest news

Cancer study seeks help from ethnic minority women.

22 November 2023

Women from ethnic minority backgrounds with a personal connection to breast cancer are being asked to join a new group to support a study aiming to improve patients’ experiences.

ALUMNI DESTINATIONS

Find out what our graduates have gone on to do in the cancer research sector

The University of Manchester

Alternatively, use our A–Z index

Cancer Sciences

Attend an open day

PhD/MPhil Cancer Sciences / Overview

Year of entry: 2024

  • View full page

We require applicants to hold, or be about to obtain, an Upper Second class Honours degree, or the equivalent qualification gained outside the UK, in a related subject area for entry to a PhD programme. A Lower Second class Honours degree may be considered if applicants also hold a Master's degree with a Merit classification.

Full entry requirements

See full guidance on how to choose a project and submit an application on our websi te . You should then complete the online admissions application form to apply for this programme. Ensure you include all required supporting documents at the time of submission, or this may delay the processing of your application.

Application deadlines

You must submit your application for a postgraduate research programme before the relevant deadline to be considered. You will not be able to apply after these deadlines have passed.

  • January entry: 15 October (of the year prior entry)
  • April entry: 15 January (year of entry)
  • September entry: 15 June (year of entry)

Programme options

Programme overview.

  • Learn from some of Europe's leading researchers while undertaking your own project.
  • Access some of the best research facilities in the world at both the University and in hospitals around Greater Manchester.
  • Undergo training in transferable skills critical to developing early-stage researchers and professionals through the Doctoral Academy's training programme.
  • Conduct research at a university ranked 6th in the UK (QS World University Rankings 2023).

For entry in the academic year beginning September 2024, the tuition fees are as follows:

  • PhD (full-time) UK students (per annum): Standard £h, Low £11,000, Medium £17,500, High £23,000 International, including EU, students (per annum): Standard £27,000, Low £28,500, Medium £34,500, High £40,500
  • PhD (part-time) UK students (per annum): Standard £j, Low £5,500, Medium £8,750, High £11,500 International, including EU, students (per annum): Standard £13,500, Low £14,250, Medium £17,250, High £20,250

Further information for EU students can be found on our dedicated EU page.

Contact details

Programmes in related subject areas.

Use the links below to view lists of programmes in related subject areas.

  • Biosciences

Regulated by the Office for Students

The University of Manchester is regulated by the Office for Students (OfS). The OfS aims to help students succeed in Higher Education by ensuring they receive excellent information and guidance, get high quality education that prepares them for the future and by protecting their interests. More information can be found at the OfS website .

You can find regulations and policies relating to student life at The University of Manchester, including our Degree Regulations and Complaints Procedure, on our regulations website .

phd cancer uk

  • Skip to main content

We use cookies

Necessary cookies.

Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.

Analytics cookies

Analytical cookies help us improve our website. We use Google Analytics. All data is anonymised.

Hotjar and Clarity

Hotjar and Clarity help us to understand our users’ behaviour by visually representing their clicks, taps and scrolling. All data is anonymised.

Privacy policy

  • Postgraduate study

Postgraduate research opportunities A-Z

  • Cancer Sciences
  • Staff research interests search

Postgraduate research  

Cancer Sciences PhD/iPhD/MSc (Research)

cancer sciences

The School of Cancer Sciences is a broad-based, research intensive institution with a global reach. We span fundamental cancer biology, translational and clinical cancer research with a major focus on cancer genomics and disease-specific research. Our primary goal is to deliver world-class research that can be translated to patient benefit and to provide a leading-edge environment for research and training.

Research projects

Iphd self-funded projects (november-april).

Our  Integrated PhD combines an MSc and PhD project in a 1+3+1 format. You can select from the below projects and indentify your chosen MSc from the options listed on the project.

Please note that you can apply for the below PhD projects outwith the IPhD route.

Evaluation of combination therapies targeting DNA damage repair signalling pathways in acute myeloid leukaemia

Supervisors : Heather Jorgensen , Helen Wheadon ,  Xu Huang

MSc choice:  Cancer Research & Precision Oncology [MSc]

Project description : Acute myeloid leukaemia (AML) is an aggressive cancer affecting mostly adult and elderly patients. It has a very poor 5-year survival of <20% in the UK. Oncogene driven genomic instability leads to accumulation of DNA damage; this is a key and common phenomenon in AML cells, that could be therapeutically targeted. Targeted inhibitor efficacy as single agents in clinical trials has been limited, partly due to the activation of alternative compensatory DNA damage response (DDR) pathways therefore rational combination strategies may be more appropriate.

We previously established a family of histone demethylases as critical and selective oncogenic factors in AML. Genetic knockdown or pharmacological inhibition of family members was sufficient to induce apoptosis in a broad spectrum of human AML cell lines and primary patient blasts with no effect on normal haematopoiesis, indicating leukaemia cells are more sensitive to inhibition thereby offering a potential therapeutic window.

We hypothesise that a combination treatment of DDRi with histone demethylase inhibitor may result in enhanced cytotoxic effects in human AML cells. Our preliminary data indeed show promising synergistic lethality activity with this combination in human AML cell line suspension culture. In this project we wish to further evaluate histone demethylase inhibitors as single agents or in combination with DDRi in primary patient blasts to inform future clinical trial design.

Methodology : We have a collection of individual primary AML patient samples and normal human bone marrow cells in our Glasgow biobank. An in vitro co-culture system has been established in our laboratory that mimics in vivo bone marrow microenvironment, that has been demonstrated to be a reproducible and reliable system for assessing clonal function and drug efficacy in primary AML cells. Functional assays including cell proliferation assay, cell apoptosis assay and colony formation assays will be performed. These data will be correlated with gene expression in each patient sample.

  • To validate the efficacy of histone demethylase inhibitor monotherapy or in combination with DDRi in stratified AML patient blasts.
  • To evaluate biomarker expression pattern in AML patient samples following single or combination treatment.
  • ME Massett, et al (2021): A KDM4A-PAF-1-mediated epigenomic network is essential for acute myeloid leukemia cell self-renewal and survival. Cell Death Dis 12(6):573. doi: 10.1038/s41419-021-03738-0.
  • L Monaghan, et al (2019): The emerging role of H3K9me3 as a potential therapeutic target in acute myeloid leukaemia. Front Oncol doi.org/10.3389/fonc.2019.00705

Investigating the prognostic value of spatial immunophenotypes in lung cancer

Supervisors:   Xiao Fu ,  John Le Quesne

Project description : Tumour microenvironments (TMEs) profoundly influence cancer progression and shape the response to anti-cancer therapy. Recent advances in digital pathology and innovative data analytics including machine learning have enhanced our ability to identify clinically relevant spatial characteristics of TMEs [1]. In lung cancer, several deep learning studies using Haematoxylin and Eosin (H&E) images have demonstrated that the spatial organisation of stromal and immune cell populations within the TME are relevant to tumour evolution and patient survival outcomes [2-4].

This PhD project will seek to investigate the prognostic value of spatial immunophenotypes in lung cancer combining high-plex imaging, spatial data analysis, and machine learning. One arm of the project will seek to engineer diverse quantitative features (e.g., adapting concepts and metrics from network science [5] to characterise cellular graphs) of the spatial immunophenotypes that are mapped in high-plex immunofluorescence images and evaluate their prognostic values in lung cancer. The other arm of the project will seek to develop deep learning models (e.g., adapting methods in [6]) based on spatial cellular graphs constructed from these images to predict clinical outcomes.

The research will be carried out using two comprehensively annotated cohorts of non-small-cell lung cancer patients, including LATTICe-A cohort (Leicester Archival Thoracic Tumour Investigatory Cohort- Adenocarcinoma), which comprises 1000 resected primary lung adenocarcinomas, and the Glasgow early non-small cell lung cancer cohort, which will comprise 1000 cases (including squamous cell carcinoma and other non-small cell varieties of lung cancer) upon completion next year. Several high-plex imaging methods (e.g., Vectra Polaris, PhenoCycler) will be applied to map spatial immunophenotypes, which are in addition to abundant genomic and RNA sequencing data as well as H&E images of the same tumours. This project will be jointly supervised by Xiao Fu and John Le Quesne. The student will have an exciting opportunity to receive training in state-of-the-art imaging techniques, quantitative data analysis, and machine learning. The successful candidate will join the dynamic and collaborative research environment of the CRUK Beatson Institute, working with a diverse multidisciplinary team of computer scientists, bioinformaticians, clinicians, and experimental scientists.

  • Fu X, Sahai E, Wilkins A. Application of digital pathology-based advanced analytics of tumour microenvironment organisation to predict prognosis and therapeutic response. J Pathol. 2023;260(5):578-591. doi:10.1002/path.6153
  • AbdulJabbar K, Raza SEA, Rosenthal R, et al. Geospatial immune variability illuminates differential evolution of lung adenocarcinoma. Nat Med. 2020;26(7):1054-1062. doi:10.1038/s41591-020-0900-x
  • Zhang H, AbdulJabbar K, Moore DA, et al. Spatial Positioning of Immune Hotspots Reflects the Interplay between B and T Cells in Lung Squamous Cell Carcinoma. Cancer Res. 2023;83(9):1410-1425. doi:10.1158/0008-5472.CAN-22-2589
  • Quiros AC, Coudray N, Yeaton A, et al. Mapping the landscape of histomorphological cancer phenotypes using self-supervised learning on unlabeled, unannotated pathology slides. arXiv. 2023
  • Albert-László Barabási. Network Science. Cambridge University Press. 2016. http://networksciencebook.com/
  • Wu Z, Trevino AE, Wu E, et al. Graph deep learning for the characterization of tumour microenvironments from spatial protein profiles in tissue specimens. Nat Biomed Eng. 2022;6(12):1435-1448. doi:10.1038/s41551-022-00951-w

Investigating the role of autophagy and mitochondrial function in leukaemic stem cells

Supervisors : Vignir Helgason ,  Eric Kalkman

Our lab is interested in biological processes that contribute to drug resistance in myeloid leukaemias, with particular focus on leukaemic stem cells (LSCs).

Introduction : Chronic myeloid leukaemia (CML) is caused by a reciprocal chromosomal translocation within a haemopoietic stem cell. This leads to transcription of BCR-ABL, a constitutively active tyrosine kinase that is necessary to induce CML.

The development of the tyrosine kinase inhibitor (TKI) significantly improved the life expectancy of CML patients; however, we have shown that disease persistence is caused by the remarkable ability of CML LSCs to survive, despite complete BCR-ABL inhibition mediated by TKI treatment1,2. Acute myeloid leukaemia (AML) is a more heterogeneous, involving different disease-causing genetic mutations. First line treatment for AML patients consists of chemotherapy, aiming at inducing remission. Generally, five-year survival rate in AML remains at a dismal 20%.

Activating internal tandem duplication mutations in FLT3 (FLT3-ITD), detected in about 20% of AML, represents driver mutations and a valid therapeutic target in AMLFLT-ITD. However, although new FLT3 inhibitors have begun to show promising clinical activity it is unlikely that they will have durable effects as single agents In recent years there has been resurgence in interest in autophagy, energy metabolism and mitochondria function as a possible area for development of novel anti-cancer agents.

We recently developed improved protocols for autophagy and metabolic assays in rare LSCs and highlighted mitochondrial oxidative phosphorylation (OXPHOS) as a metabolic dependency in CML LSCs3. Primitive AML cells have also been shown to depend on increased mitochondrial respiration4,5. We will therefore further investigate mitochondrial metabolism and through validation of drug-repurposing screen, identify new clinically applicable drugs that inhibit OXPHOS in CML, and in AML where improved therapy options with acceptable toxicities are urgently needed.

Hypothesis/aims : Our working hypothesis is that autophagy and deregulated mitochondrial metabolism in LSCs renders them sensitive to inhibition of the ULK1 autophagy complex and pathways that sustain mitochondrial OXPHOS. Our first aim is to use complementary functional and omic approaches to further assess the dependency of CML/AML LSCs to recycle or oxidise major mitochondrial fuels (objective 1). Our second aim is to test ULK1 inhibitors6 and FDA-approved OXPHOS inhibitors (which we have recently identified through drug-repurposing screening), in combination with TKI treatment, for eradication of CML and AMLFLT3-ITD/TKD LSCs (objective 2).

Deliverables : This project will therefore promote identification of a core fuel pathway signature of CML/AML LSCs and a set of new potentially selective LSC-specific metabolic drug targets (objective 1). The student will also use state-of-the-art in vitro and in vivo models to test clinically relevant drugs, which will in the longer term, facilitate the translation of our findings into the clinic, with the overall aim for CML and AML LSC eradication.

  • Holyoake, T.L., et al. Immunological reviews. 106-23 (2015).
  • Hamilton, A., et al. Blood. 1501-10 (2012).
  • Kuntz, E.M., et al. Nat Med. 1234-40 (2017).
  • Skrtic, M., et al. Cancer Cell. 674-88 (2011).
  • Lagadinou, E.D., et al. Cell Stem Cell. 329-41 (2013).
  • Ianniciello, A., et al. Sci Transl Med. (2021)

Investigation of new therapeutic approaches to combat viral-associated cancer

Supervisor: Dr. Joanna B. Wilson

Background:  Epstein-Barr virus (EBV) is a human Herpesvirus that is associated with several forms of human cancer. The virus leads to a life long infection, avoiding eradication by the immune system and has evolved intriguing tricks to do this. In the lab we investigate the role of key viral genes in disease processes, their mechanism of action at the molecular level and how they perturbate the immune system. Central to this are the mechanisms by which viral proteins disrupt normal cellular processes. New insights into viral action permit an exploration into novel therapeutic approaches to combat EBV-associated cancer.

Aims : To assess the efficiency of novel treatments in killing viral infected tumour cells and to explore the mechanism of action of such drugs in targeting the function of selected viral proteins

Techniques:  The project will involve the use of several molecular biological and genetical techniques to examine protein, DNA, RNA and molecular interactions, as well as immunological and cell culture methods, also high resolution imaging.

  • AlQarni, S., Al-Sheikh, Y., Campbell, D., Drotar, M., Hannigan, A., Boyle, S., Herzyk, P., Kossenkov, A., Armfield, K., Jamieson, L., Bailo, M., Lieberman, P., Tsimbouri, P. and Wilson, J.B. (2018) Lymphomas driven by Epstein-Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2. Oncogene (in the press)
  • Gnanasundram, S.V., Pyndiah, S., Daskalogianni, C., Armfield, K., Nylander, K. , Wilson, J.B. and Fåhraeus,, R. (2017) PI3Kd activates E2F1 synthesis in response to EBNA1-induced mRNA translation stress. Nature Communications 8:2103, doi:10.1038/s41467-017-02282-w Gao, X., Lampraki, E., Al-Khalidi, S., Qureshi, M.A., Desai, R. and Wilson, J.B. (2017) N-acetyl cysteine (NAC) ameliorates Epstein-Barr virus latent membrane protein 1 induced chronic inflammation. PLoS-ONE 12 (12) e0189167
  • Deschamps, T., Quentin, B, Leske, D.M., MacLeod, R., Mompelat, D., Tafforeau, L., Lotteau, V., Baillie, G.S., Gruffat, H., Wilson, J.B. and Manet, E. (2017) Epstein-Barr Virus Nuclear Antigen 1 (EBNA1) interacts with Regulator of Chromosome Condensation (RCC1) dynamically throughout the cell cycle. J. Gen. Virol. 98:251-265 PMID:28284242
  • Hussain, M., Gatherer, D. and Wilson, J.B. (2014) Modelling the structure of full-length Epstein-Barr Virus Nuclear Antigen 1. Virus Genes 49:358-372 PMID: 25011696

Mechanisms of metastasis: Defining how the sialomucin Podocalyxin drives metastatic colorectal cancer

Supervisors:   David Bryant ,  Owen Sansom

MSc choices:  Cancer Research & Precision Oncology [MSc]  

Summary:  The majority of cancer-related deaths are associated with metastasis from the primary tumour. Cancer metastasis treatment is therefore a major unmet need in the clinic. The sialomucin Podocalyxin is a potential biomarker and molecular regulator of metastasis across a number of tumour types.

In this PhD project, the candidate will utilise a combination of cutting-edge mouse models of metastatic colorectal cancer and mini-tumour avatars in the laboratory to understand how Podocalyxin drives metastasis. This will include identification of those colorectal tumours in which Podocalyxin levels can be a biomarker to indicate which patients will have metastases, and whether function-blocking antibodies can be an effective treatment in vivo to avert metastasis. The candidate will receive outstanding training in mouse models of cancer, genetic editing and molecular analysis of cancer cells, 3-Dimensional culture techniques, and advanced live imaging and analysis. The PhD project is aimed at improving our understanding of the mechanisms of metastasis and identifying potential molecularly targeted therapies.

  • Román-Fernández A, Mansour MA, Kugeratski FG, Anand J, Sandilands E, Galbraith L, Rakovic K, Freckmann EC, Cumming EM, Park J, Nikolatou K, Lilla S, Shaw R, Strachan D, Mason S, Patel R, McGarry L, Katoch A, Campbell KJ, Nixon C, Miller CJ, Leung HY, Le Quesne J, Norman JC, Zanivan S, Blyth K, Bryant DM. Spatial regulation of the glycocalyx component podocalyxin is a switch for prometastatic function. Sci Adv. 2023 Feb 3;9(5):eabq1858. doi: 10.1126/sciadv.abq1858. Epub 2023 Feb 3. PubMed PMID: 36735782; PubMed Central PMCID: PMC9897673.
  • Jackstadt R, van Hooff SR, Leach JD, Cortes-Lavaud X, Lohuis JO, Ridgway RA, Wouters VM, Roper J, Kendall TJ, Roxburgh CS, Horgan PG, Nixon C, Nourse C, Gunzer M, Clark W, Hedley A, Yilmaz OH, Rashid M, Bailey P, Biankin AV, Campbell AD, Adams DJ, Barry ST, Steele CW, Medema JP, Sansom OJ. Epithelial NOTCH Signaling Rewires the Tumor Microenvironment of Colorectal Cancer to Drive Poor-Prognosis Subtypes and Metastasis. Cancer Cell. 2019 Sep 16;36(3):319-336.e7. doi: 10.1016/j.ccell.2019.08.003. PMID: 31526760; PMCID: PMC6853173.

Microenvironment in paediatric and adult acute myeloid leukaemia

Supervisors: Dr Karen Keeshan ,  Prof Brenda Gibson

Abstract: Acute myeloid leukaemia (AML) is a genetically and phenotypically heterogeneous disease that is characterized by a block in myeloid differentiation, as well as enhanced proliferation and survival. It affects people of all ages with an incidence of 2-3 per 100 000 per annum in children, increasing to 15 per 100 000 per annum in older adults. The relapse risk for childhood AML remains unacceptably high and relapse is the commonest cause of death. Multiple courses of chemotherapy remain the mainstay of treatment in adult and childhood AML but a ceiling of benefit has been reached and toxicity is significant (Chaudhury et al, 2015). There have been few, if any, new treatments in the past 30 years and there is a pressing need for novel effective therapies in AML.

The treatment of paediatric AML is in essence extrapolated from that of adults with AML. Our previous work (Chaudhury et al, 2015) in addition to recent timely publications (Beerman et al 2015) have questioned the appropriateness of this approach which assumes that a similar aetiology underlies AML in the young and old. There is additional evidence that disease characteristics differ between a paediatric and adult population with AML (Appelbaum 2006; Creutzig et al. 2008). Functional interplay between AML cells and the bone marrow microenvironment is a distinctive characteristic of AML disease. AML cells in the adult bone marrow BM reside in leukaemic niches (Colmone et al 2008) that support leukaemic cell survival and expansion. The importance of the microenvironment in paediatric versus adult AML (fetal liver, cord blood, bone marrow) and its role is disease characteristics has not been well explored. Our lab focuses on the proliferation and self-renewal capabilities of the leukaemic cell and the influence of the leukaemic niche. We hypothesize that the microenvironment influences the initiation, maintenance, and aggressiveness of paediatric and adult AML disease.

Methods & approaches : This project will investigate the role of the microenvironment in AML disease initiation and maintenance. We will focus on genetically distinct subtypes of paediatric and adult using a number of models and approaches including: Bone marrow transduction and transplantation (BMT) murine models: expression of AML oncogenes in viral constructs and using CRISPR/Cas9 gene editing approaches; assessments on disease in vivo; Stromal co-cultures and transcriptional profiling using haematopoietic stem cells; primary AML samples from paediatric and adult patients. The project will also employ flow cytometry, cellular and molecular biology technologies. This PhD studentship offers extensive dual training in both fundamental and translational biology of leukaemia, an environment encompassing clinical and basic researchers, and training opportunities as part of the college graduate program.

  • Chaudhury SS, Morison JK, Gibson BES, Keeshan K. Insights into cell ontogeny, age and acute myeloid leukaemia. Experimental Hematology. 2015 Jun 4.
  • Beerman I, Rossi DJ. Epigenetic Control of Stem Cell Potential during Homeostasis, Aging, and Disease. Cell Stem Cell. 2015 Jun;16(6):613–25.
  • Appelbaum, F.R., 2006. Age and acute myeloid leukemia. Blood, 107(9), pp.3481–3485.
  • Creutzig, U. et al., 2008. Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A. Cancer, 112(3), pp.562–571.
  • Colmone A, Amorim M, Pontier AL, Wang S, Jablonski E, Sipkins DA. Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science. 2008;322(5909):1861-1865.

Role of Mitochondrial Reprogramming in PPARG Driven Prostate Cancer

Supervisors:   Imran Ahmad ,  Tom MacVicar

MSc choices:  Cancer Research & Precision Oncology [MSc]

Summary:  Remarkable prostate cancer cell metabolic flexibility and plasticity enables tumours to grow and combat androgen therapy. Mitochondria are essential organelles that support tumour adaptation, with changes in form and function that are dynamically reprogrammed during tumorigenesis. Previous work in our group has identified the key role of the metabolic regulator PPARG in driving metastatic prostate cancer.

In this innovative PhD project, the candidate will use 3D tumour models combined with genetically engineered mouse models to investigate how mitochondria contribute to tumorigenesis and treatment resistance. The candidate will study mitochondrial reprogramming in these models with state-of-the-art compartmentalised metabolomic and proteomic techniques. These studies will improve our basic understanding of mitochondrial reprogramming in tumours and may identify novel therapeutic targets for prostate cancer.

  • Galbraith LCA, Mui E, Nixon C, Hedley A, Strachan D, MacKay G, Sumpton D, Sansom OJ, Leung HY, Ahmad I. “PPAR-gamma induced AKT3 expression increases levels of mitochondrial biogenesis driving prostate cancer”. Oncogene 2021; doi: 10.1038/s41388-021-01707-7

Therapeutic interventions to attenuate metastasis in colorectal cancer

Summary:  One of the most frequently altered pathways in human cancers is lipid signalling through PI3K (Phosphatidylinositol-3-kinase). Almost a quarter of all human cancers have mutation in PI3K or in PTEN, the phosphatase that reverses the action of PI3K. Previous work from our groups have generated genetically engineered mouse models that closely mimic patients with highly metastastic, poor outcome colorectal cancer. Additional work has identified molecular vulnerabilities in ovarian cancer downstream of PI3K pathway alteration (i.e. PTEN loss).

In this PhD project, the candidate will join a team of researchers utilise a combination of cutting-edge mouse models of metastatic colorectal cancer and mini-tumour avatars in the laboratory to understand how inhibiting this PI3K pathway may be a potential treatment to perturb tumourigenesis and metastasis. The candidate will receive outstanding training in mouse models of cancer, genetic editing and molecular analysis of cancer cells, 3-Dimensional culture techniques, and advanced live imaging and analysis. The PhD project is aimed at improving our understanding of the existing therapies to the PI3K pathway may be utilised to treat colorectal cancer and potentially lower metastatic burden in colorectal cancer.

  • Nikolatou K, Sandilands E, Román-Fernández A, Cumming EM, Freckmann E, Lilla S, Buetow L, McGarry L, Neilson M, Shaw R, Strachan D, Miller C, Huang DT, McNeish IA, Norman JC, Zanivan S, Bryant DM. PTEN deficiency exposes a requirement for an ARF GTPase module for integrin-dependent invasion in ovarian cancer. EMBO J. 2023 Sep 18;42(18):e113987. doi: 10.15252/embj.2023113987. Epub 2023 Aug 14. PMID: 37577760; PMCID: PMC10505920.

Understanding and exploiting immunogenic cell death to treat cancer

Supervisors:  Stephen Tait ,  Ed Roberts

Project description:  Cell death both prevents and treats cancer. New anti-cancer therapies that directly target cell death are revolutionising the treatment of cancer. Nevertheless, a major problem to effective cancer treatment is the emergence of treatment resistance. We are interested in killing cancer cells in a way that alerts the immune system to the presence of cancer - in essence harnessing the power and adaptability of tumour immunity to eradicate cancer. Our focus is on mitochondrial apoptosis - we have found that blocking caspase protease activity makes cell death immunogenic.

This PhD project will seek to understand why such caspase-inhibited cell death is immunogenic - both at the level of the dying cell but also in understanding how the immune system responds to the dying cell. We will employ novel approaches to inhibit caspase activity. In short, this exciting project will focus on discovery science with clear translation impact for cancer treatment.

The techniques it will entail will be varied but include CRISPR-Cas9 genome editing, super-resolution microscopy and in vivo modelling of cancer. This will be a collaborative project jointly supervised by Stephen Tait and Ed Roberts. You will join a young, dynamic interdisciplinary research team, based withing the CR-UK Beatson Institute with access to cutting edge technology.

  • Targeting immunogenic cell death in cancer . Ahmed A, Tait SWG. Mol Oncol. 2020 Dec;14(12):2994-3006. doi: 10.1002/1878-0261.12851. Epub 2020 Dec 1.
  • Mitochondrial permeabilization engages NF-κB-dependent anti-tumour activity under caspase deficiency

We are part of a national centre of excellence in the fight against cancer carrying out a programme of world-class science directed at understanding the molecular changes that cause cancer. We are working to translate scientific discoveries into new drugs or diagnostic and prognostic tools that benefit cancer patients, taking new therapies through preclinical and clinical trials.

The School of Cancer Sciences  is a major component of the Cancer Research UK West of Scotland Cancer Centre. There are currently 51  research groups  housed in magnificent new research buildings at the Beatson Institute for Cancer Research, the Paul O’Gorman Leukaemia Research Centre, the CRUK clinical trials unit (CTU) and the Wolfson Wohl Cancer Research Centre. Our facilities house a number of state-of-the-art technologies that underpin our key research themes.

Individual research projects are tailored around the expertise of principal investigators within our Schools. Basic and clinical projects are also available for study.

A variety of approaches are used, including molecular biology, biochemistry, bioinformatics, genetics, cancer modelling and cell biology (including advanced in vitro and in vivo imaging), immunology and polyomics (genomics, transcriptomics, proteomics and metabolomics).

Specific areas of interest include:

  • cancer biology and cell signalling
  • epigenetics
  • cancer stem cell biology
  • cancer imaging
  • chemoresistance in cancer
  • cancer and ageing
  • regulation of cancer cell death processes
  • genetics, genomics and systems medicine 
  • immunotherapy for cancer
  • cancer clinical trials

Study options

  • Duration:  3/4 years full-time; 5 years part-time

Individual research projects are tailored around the expertise of principal investigators.

Integrated PhD programmes (5 years)

Our  Integrated PhD  allows you to combine masters level teaching with your chosen research direction in a 1+3+1 format. 

International students with MSc and PhD scholarships/funding do not have to apply for 2 visas or exit and re-enter the country between programmes. International and UK/EU students may apply.

Taught masters level modules are taken alongside students on our masters programmes. Our research-led teaching supports you to fine tune your research ideas and discuss these with potential PhD supervisors. You will gain a valuable introduction to academic topics, research methods, laboratory skills and the critical evaluation of research data. Your grades must meet our requirements in order to gain entry on to your pre-selected PhD research project. If not, you will have the options to pay outstanding MSc fees and complete with masters degree only.

Years 2, 3 and 4

PhD programme with research/lab work, completing an examinable piece of independent research in year 4.

Thesis write up.

MSc (Research)

  • Duration : 1 year full-time; 2 years part-time

Entry requirements

A 2.1 Honours degree or equivalent.

English language requirements

For applicants whose first language is not English, the University sets a minimum English Language proficiency level.

International English Language Testing System (IELTS) Academic module (not General Training)

  • 6.5 with no subtests under 6.0
  • Tests must have been taken within 2 years 5 months of start date. Applicants must meet the overall and subtest requirements using a single test.

Common equivalent English language qualifications accepted for entry to this programme:

Toefl (ibt, my best or athome).

  • 79; with Reading 13; Listening 12; Speaking 18;Writing 21
  • Tests must have been taken within 2 years 5 months of start date. Applicants must meet the overall and subtest requirements , this includes TOEFL mybest.

Pearsons PTE Academic

  • 59 with minimum 59 in all subtests

Cambridge Proficiency in English (CPE) and Cambridge Advanced English (CAE)

  • 176 overall, no subtest less than 169

Oxford English Test

  • Oxford ELLT 7
  • R&L: OIDI level no less than 6 with Reading: 21-24 Listening: 15-17
  • W&S: OIDI level no less than 6

Trinity College Tests

Integrated Skills in English II & III & IV: ISEII Distinction with Distinction in all sub-tests.

University of Glasgow Pre-sessional courses

Tests are accepted for 2 years following date of successful completion.

Alternatives to English Language qualification

  • students must have studied for a minimum of 2 years at Undergraduate level, or 9 months at Master's level, and must have complete their degree in that majority-English speaking country  and  within the last 6 years
  • students must have completed their final two years study in that majority-English speaking country  and  within the last 6 years

For international students, the Home Office has confirmed that the University can choose to use these tests to make its own assessment of English language ability for visa applications to degree level programmes. The University is also able to accept UKVI approved Secure English Language Tests (SELT) but we do not require a specific UKVI SELT for degree level programmes. We therefore still accept any of the English tests listed for admission to this programme.

Pre-sessional courses

The University of Glasgow accepts evidence of the required language level from the English for Academic Study Unit Pre-sessional courses. We also consider other BALEAP accredited pre-sessional courses:

  • School of Modern Languages and Cultures: English for Academic Study
  • BALEAP guide to accredited courses

Fees and funding

  • UK: To be confirmed by UKRI [23/24 fee was £4,712]
  • International & EU: £30,240

Prices are based on the annual fee for full-time study. Fees for part-time study are half the full-time fee.

Irish nationals who are living in the Common Travel Area of the UK, EU nationals with settled or pre-settled status, and Internationals with Indefinite Leave to remain status can also qualify for home fee status.

  • Fee status and policies

Alumni discount

We offer a 20% discount to our alumni on all Postgraduate Research and full Postgraduate Taught Masters programmes. This includes University of Glasgow graduates and those who have completed Junior Year Abroad, Exchange programme or International Summer School with us. The discount is applied at registration for students who are not in receipt of another discount or scholarship funded by the University. No additional application is required.

Possible additional fees

  • Re-submission by a research student £540
  • Submission for a higher degree by published work £1,355
  • Submission of thesis after deadline lapsed £350
  • Submission by staff in receipt of staff scholarship £790

Depending on the nature of the research project, some students will be expected to pay a bench fee (also known as research support costs) to cover additional costs. The exact amount will be provided in the offer letter.

The iPhD  is not supported by University of Glasgow Scholarship/Funding

  • Recruitment at the Beatson Institute  (postdoctoral/clinical research fellowships and PhD studentships)
  • BBSRC Doctoral Training Partnerships
  • External funding information

The College of Medical, Veterinary and Life Sciences Graduate School provides a vibrant, supportive and stimulating environment for all our postgraduate students. We aim to provide excellent support for our postgraduates through dedicated postgraduate convenors, highly trained supervisors and pastoral support for each student.   Our overarching aim is to provide a research training environment that includes:

  • provision of excellent facilities and cutting edge techniques
  • training in essential research and generic skills
  • excellence in supervision and mentoring
  • interactive discussion groups and seminars
  • an atmosphere that fosters critical cultural policy and research analysis
  • synergy between research groups and areas
  • extensive multidisciplinary and collaborative research
  • extensive external collaborations both within and beyond the UK 
  • a robust generic skills programme including opportunities in social and commercial training

How to apply

Identify potential supervisors.

All Postgraduate Research Students are allocated a supervisor who will act as the main source of academic support and research mentoring. You may want to identify a potential supervisor and contact them to discuss your research proposal before you apply. Please note, even if you have spoken to an academic staff member about your proposal you still need to submit an online application form.

You can find relevant academic staff members with our staff research interests search .

IPhD applicants do not need to contact a supervisor, as you will choose from a list of IPhD projects. Each project has named supervisors.

Gather your documents

Before applying please make sure you gather the following supporting documentation:

  • Final or current degree transcripts including grades (and an official translation, if needed) – scanned copy in colour of the original document.
  • Degree certificates (and an official translation, if needed): scanned copy in colour of the original document
  • Two references on headed paper and signed by the referee. One must be academic, the other can be academic or professional [except iPhD applicants, where only one academic or professional reference is required]. References may be uploaded   as part of the application form or you may enter your referees contact details on the application form. We will then email your referee and notify you when we receive the reference.  We can also accept confidential references direct to  [email protected] , from the referee’s university or business email account.
  • Research proposal, CV, samples of written work as per requirements for each subject area. iPhD applicants do not need to submit any of these as you will start your programme by choosing a masters.
  • Completed  College of MVLS Postgraduate Research Cover Letter

Notes for iPhD applicants

  • add 'I wish to study the MSc in (select MSc from IPhD project choices) as the masters taught component of the IPhD' in the research proposal box
  • For supervisor name, please ensure you write the named supervisors from your chosen IPhD project.

Before you apply

PhD/MSc/MD: email  [email protected]

iPhD: email  [email protected]

After you have submitted your application

PhD/MSc/MD/iPhD:  contact our Admissions team

Any  references  may be submitted by email to:  [email protected]

Clarice Pears building

  • Schools & departments

Postgraduate study

Cancer (Edinburgh Cancer Research Centre) PhD, MScR

Awards: PhD, MScR

Study modes: Full-time, Part-time

Funding opportunities

Programme website: Cancer (Edinburgh Cancer Research Centre)

Postgraduate Discovery Day

Join us online on Wednesday 21 February to learn about student life, how to apply, and more.

See the full schedule and register

Research profile

Edinburgh Cancer Research UK Centre (ECRC) strives to take a comprehensive approach to cancer research, combining both laboratory-based research and clinical approaches.

Overall the centre studies the genetic and biological basis of cancer and disease pathology, and devises and test new forms of therapy arising from our basic, translational and clinical research programs.

Our ultimate aim is to carry out high quality research into effective cancer prevention, diagnosis and treatment, as well as the symptoms associated with cancer.

ECRC is part of the Edinburgh Medical School's Deanery of Molecular, Genetic and Population Health Sciences at the Western General Hospital. This centre, as part of a unit of Hospital-Based Clinical Subjects, was rated 5* in the most recent Research Assessment Exercise.

We have 18 academic staff, 40 research staff, 35 support staff and 22 students.

For information on projects available, please see the Cancer Research UK Edinburgh Centre webpage:

  • Cancer Research UK Edinburgh Centre

Funded Projects

There is often funding available for PhD study - see Scholarships and Funding section on this page for more information and links. We rarely have funding available for Masters by Research projects but do welcome applications from those able to self-fund.

Entry requirements

These entry requirements are for the 2024/25 academic year and requirements for future academic years may differ. Entry requirements for the 2025/26 academic year will be published on 1 Oct 2024.

A UK 2:1 honours degree or its international equivalent.

International qualifications

Check whether your international qualifications meet our general entry requirements:

  • Entry requirements by country
  • English language requirements

Regardless of your nationality or country of residence, you must demonstrate a level of English language competency at a level that will enable you to succeed in your studies.

English language tests

We accept the following English language qualifications at the grades specified:

  • IELTS Academic: total 6.5 with at least 6.0 in each component.
  • TOEFL-iBT (including Home Edition): total 92 with at least 20 in each component. We do not accept TOEFL MyBest Score to meet our English language requirements.
  • C1 Advanced ( CAE ) / C2 Proficiency ( CPE ): total 176 with at least 169 in each component.
  • Trinity ISE : ISE II with distinctions in all four components.
  • PTE Academic: total 62 with at least 59 in each component.

Your English language qualification must be no more than three and a half years old from the start date of the programme you are applying to study, unless you are using IELTS , TOEFL, Trinity ISE or PTE , in which case it must be no more than two years old.

Degrees taught and assessed in English

We also accept an undergraduate or postgraduate degree that has been taught and assessed in English in a majority English speaking country, as defined by UK Visas and Immigration:

  • UKVI list of majority English speaking countries

We also accept a degree that has been taught and assessed in English from a university on our list of approved universities in non-majority English speaking countries (non-MESC).

  • Approved universities in non-MESC

If you are not a national of a majority English speaking country, then your degree must be no more than three and a half years old at the beginning of your programme of study.

Find out more about our language requirements:

Fees and costs

Tuition fees, scholarships and funding, featured funding.

  • College of Medicine & Veterinary Medicine funding opportunities
  • Research scholarships for international students
  • Principal's Career Development PhD Scholarships

UK government postgraduate loans

If you live in the UK, you may be able to apply for a postgraduate loan from one of the UK’s governments.

The type and amount of financial support you are eligible for will depend on:

  • your programme
  • the duration of your studies
  • your tuition fee status

Programmes studied on a part-time intermittent basis are not eligible.

  • UK government and other external funding

Other funding opportunities

Search for scholarships and funding opportunities:

  • Search for funding

Further information

  • Studentship Administrator, Pauline McDonald
  • Phone: +44 (0)131 651 5771
  • Contact: [email protected]
  • Postgraduate Director, Val Brunton
  • Edinburgh Cancer Research Centre
  • Institute of Genetics and Cancer
  • Crewe Road South
  • Central Campus
  • Programme: Cancer (Edinburgh Cancer Research Centre)
  • School: Edinburgh Medical School: Molecular, Genetic & Population Health Sciences
  • College: Medicine & Veterinary Medicine

Select your programme and preferred start date to begin your application.

PhD Cancer (Edinburgh Cancer Research Centre) - 3 Years (Full-time)

Phd cancer (edinburgh cancer research centre) - 6 years (part-time), msc by research cancer (edinburgh cancer research centre) - 1 year (full-time), msc by research cancer (edinburgh cancer research centre) - 2 years (part-time), application deadlines.

We encourage you to apply at least one month prior to entry so that we have enough time to process your application. If you are also applying for funding or will require a visa then we strongly recommend you apply as early as possible.

  • How to apply

You must submit two references with your application.

Before making your application, you must make contact with a potential supervisor to discuss your research proposal. Further information on making a research degree application can be found on the College website:

  • How to apply for a research degree

You will be formally interviewed (in person, by video-conferencing or Skype).

Find out more about the general application process for postgraduate programmes:

Home page banner image

Cancer Research UK Manchester Institute PhD Graduate Programme

The CRUK Manchester Institute is a leading cancer research institute within the University of Manchester, and is supported by major core funding from Cancer Research UK, the largest independent cancer research organisation in the world.  The CRUK MI is at the heart of the Manchester Cancer Research Centre , a partnership that brings together the expertise, vision and resources of its founding partners: The University of Manchester, The Christie NHS Foundation Trust and Cancer Research UK, all of whom have formidable individual reputations in the fields of cancer treatment and research.  Cancer Research in Manchester is world leading. Cancer is one of The University of Manchester’s research beacons, showcasing pioneering discoveries, interdisciplinary collaboration and cross-sector partnerships that are tackling some of the biggest questions facing the planet.

In April 2017, The Paterson Building, which housed most of the Cancer Research UK Manchester Institute, suffered a major fire resulting in significant damage. We are making great progress to rebuild our world-class research facilities, and in the meantime, our studentships will either be based at the Manchester Cancer Research Centre (Oglesby Cancer Research Building), South Manchester, which has excellent facilities to carry out research, or at the internationally-renowned life sciences campus at Alderley Park. We anticipate returning to the new building and to our original site in Withington, Manchester, next to The Christie NHS Foundation Trust (Wilmslow Road, M20 4BX), UK in 2023.

CRUK MI comprises over 350 postdoctoral scientists, clinical fellows, scientific officers, administrative and technical staff, postgraduate research students and visiting fellows.  The CRUK Manchester Institute is currenty located on two sites; the Manchester Cancer Research Centre [Oglesby Cancer Research Building] and Alderley Park , Cheshire.  Both sites also house research groups that are part of the Division of Cancer Sciences, The University of Manchester.   Groups work on many aspects of cancer research, from programmes investigating the molecular and cellular basis of cancer, to those focused on translational research and the development of novel therapeutic approaches, with considerable synergy and interaction across all groups.

The CRUK Manchester Institute (CRUK MI) offers postgraduate degrees for students interested in a career involving cancer research.  The Institute considers education of research and clinical scientists to be a major investment in the future generation of cancer researchers, and has an excellent track record of launching careers in basic, translation and clinical research.  As part of this commitment,  we have an active postgraduate programme that provides first class students and clinical research fellows the opportunity to study for cancer-related PhD degrees through a training programme that aims to improve effectiveness in research, provide professional and management skills and enhance career development.  Ninety-nine percent (99%) of our students in the past 8 years have found employment after graduation; half of these are in USA or European laboratories, with 20% of these students continuing to progress in their clinical careers in the NHS. Students leave the CRUK MI with excellent career prospects across the world. 

Cancer Research UK PhD Studentships

We are committed to training the next generation of cancer research scientists, helping launch careers in basic, translational and clinical cancer research. Postgraduate students enjoy a supportive environment, a challenging project and, together with tailored training in transferable and generic skills, development as independent scientists with excellent career prospects will ensue. 

A PhD should be an exciting and stimulating time.  We are looking for talented and motivated graduates with backgrounds in biological and biomedical sciences, mathematics, computer science and/or chemistry interested in pursuing scientific research careers.  As well as benefitting from dynamic and interactive research environment, graduate students will have access to outstanding facilities within the Institute.  

Each year we recruit students to join us on our 4 year PhD programme. Cancer Research UK studentships within the Institute and we welcome applications from UK, EU and international students.  CRUK studentships are fully funded by Cancer Research UK and come with a generous tax-free stipend (living allowance) of £21,000/annum (outside of London), tuition fees and allocation of appropriate level of funding to ensure the project bench fees are fully supported.  Projects are typically conducted within a single research group, although many students find themselves interacting and collaborating with more than one group as their project matures.

Studentships are advertised on our webpages annually in October/November with interviews taking place in January/February of the academic intake year. We are flexible as to intake within University postgraduate semesters with registrations in either April or September.  Additional PhD studentships and vacancies may be advertised at various times throughout the year.

Hear from some of our current PhD students on their research and experience at the CRUK Manchester Institute here

Self-Funding Students

If you have secured your own funding (stipend, tuition, bench and living fees) to undertake and support a PhD degree, and you are interested in study with a supervisor based at the CRUK Manchester Institute, you can submit an application directly to the University of Manchester for consideration; https://www.bmh.manchester.ac.uk/study/research/apply/    Your application should clearly state how you intend to fund your studies for the duration, an outline of your proposed research and interests, supporting academic, sponsorship and financial documentation.  You will need to select "PhD Cancer Sciences" as the programme description on the application form.  Please note, regardless of funding, the CRUK Manchester Institute PhD admission criteria remains as above: a first or upper second class honours degree and minimum level of English language qualification.

Visiting Postgraduate Students (maximum 12 months)

Each year a number of students that are currently registered for a PGR programme at another institution spend time at the University undertaking research and training. All visiting students must be formally registered with the University of Manchester.

Appropriate registration of PGR student visitors on the student record system means that the University can meet its legal obligations for monitoring and oversight of students, e.g. for immigration, insurance, health and safety, and export control due diligence purposes. All students visiting the University for more than a week must be registered on Campus Solutions. Registration ensures the student experience, providing University identification, allowing access to email, access to the library and other buildings and facilities, as well as ensuring associated insurance cover.

It is, therefore, a requirement that the University of Manchester's Doctoral Academy is made aware of all visiting PGR students to enable the following:

  • approve all tuition fee levels in advance of the student arrival (by the relevant Division Senior PGR)
  • identify students that are considered to be part of a collaborative research arrangement (which attracts a one-off lower fee)*
  • formally register the student on the University system to allow the payment of appropriate fees which covers swipe card, email, library access, insurance cover for access to buildings and facilities

Tuition fees may be applied at the ‘collaborative fee’ rate when the student is attached to a supervisor as part of a genuine collaborative research initiative, or when a supervisor has relocated from another institution with their research group but the student remains registered at that institution.

If you are interested in a visiting postgraduate place to study with a supervisor based at the CRUK Manchester Institute, you should contact the proposed supervisor directly to discuss further before submitting an application to the University of Manchester for consideration.

Monitoring, Mentoring, Progression and Supervision

Students offered a PhD position at the Institute will receive high quality training in scientific research through an intellectually demanding, but achievable research project.  Projects are internally and externally peer-reviewed and approved by the Education Committee in advance of a student commencing their project.  Every student will have a main supervisor, a nominated co-supervisor to contribute their expertise, and pastoral advisor to provide impartial support and advice.  A laboratory supervisor (post-doctoral fellow or associate scientist) will ensure that day-to-day supervision is provided for technical support.

eProg is the University of Manchester's online progression system to support you through the duration of your PGR programme.  It allows you to break down the requirements of the programme into manageable goals and supports you in planning achievable targets.  eProg enables you and your supervisory team to record and reflect on your progress against agreed objectives and deadlines.  Ultimately, it helps students complete their research programme both effectively and on time with set milestones and deadlines. eProg is accessible from any location throughout your PhD.

PhD progress is monitored via a mixture of oral presentations, written reports and progress meetings.  These modes of assessment are designed not only to provide formal points at which progress is monitored, but also to help develop the presentations skills which are a fundamental part of a successful research career.  We ask our PhD students to present their data regularly within their own research groups and also at internal/external seminars throughout their project.  This focused environment is key in providing an opportunity to present and discuss your research with peers.  

CRUK Manchester Institute Education Committee 

The Education acts for postgraduate students based within a core-funded Cancer Research group.  The Education Committee's goal is for every student to have an approved research degree proposal at the commencement of their studies ensuring this is both achievable and intellectually stimulating.  Alongside the supervisory team, the Education Committee monitors student progression, attends student talks and provides written feedback to students throughout the various yearly assessment stages of their project.  

The Education Committee is staffed by the Institute's senior group leaders, operational staff and student representatives;

  • Chair and Director: Tim Somervaille
  • Ex-Officio Member:  Caroline Dive
  • Postgraduate Tutor: Santiago Zelenay
  • Postgraduate Manager: Julie Edwards
  • Academic staff members: Georges Lacaud, Claus Jorgensen, Caroline Wilkinson, Amaya Viros, Carlos Lopez Garcia, Mark Williams
  • Student Representatives:   Sophie Richardson, Florentia Mousoullou

PGR Director

The School PGR Director leads postgraduate research activities within the School and works with the Head of School — and a team of Senior Tutors at Division level – to ensure that PGR objectives and issues are addressed at both a strategic and operational level.

Postgraduate Tutor (PGT)

Within the University of Manchester's School of Medical Sciences there is an appointed Postgraduate Tutor (PGT).  The role of the PGT within the CRUK Manchester Institute is to approve eProg milestones, advise on research progress, approve theses examiners, to provide academic and pastoral support and to serve as an Education Committee member.

Meetings and Conferences

The CRUK MI runs an external seminar series featuring talks from many of the leading scientists in cancer research, which our students attend. The speakers are internationally renowned scientists and we consider it essential that our students are exposed to outstanding research from leaders in different disciplines, which will give them a broad understanding of many aspects of cancer research and basic biology. In addition, we hold a series of weekly postdoctoral research seminars and attendance from PhD students is also an integral part of their learning. While students themselves are asked to give talks at key points during their PhD, they also have opportunities to present their work at lab meetings and during student forums within the Institute.

STAy (Science TakeAway) is a Committee group run by junior scientists and students in the CRUK Manchester Institute with the aim of providing a forum for discussions and training related to research, communication of scientific engagement and development of social and networking opportunities.  STAy are keen to encourage networking, career progression and personal growth of early-career researchers. 

The CRUK Manchester Institute Colloquium takes place annually in September, and is an excellent opportunity for our new intake of students to meet other established PhD students, members of the Institute, including group leaders, postdoctoral fellows, and scientific officers.  This forum communicates up to date science in the form of oral presentations given by group leaders and second year PhD students, as well as poster presentations from a range of scientists across the Institute covering all aspects of cancer research.

Cancer Research UK contributes towards an exclusi- ve annual international PhD Student Cancer Conference (IPSCC) allowing high calibre students from top cancer research institutes across Europe to organise and present at their own scientific conference.  Core participating Institutes include the CRUK Manchester Institute, The Francis Crick, Cambridge Institute, Beatson Institute, Netherlands Cancer Institute, European School of Molecular Medicine, German Cancer Research and Max Delbruck Center for Molecular Medicine.

Manchester is a diverse and cosmopolitan city with a compact and friendly centre.  It is a vibrant and dynamic city where culture, food, music, night life, shopping and sport are second to none - all within easy access via tram, train and bus links.  There is something for everyone in Manchester!  We are also central for discovering the more tranquil surrounds of Cheshire, Peak and Lake Districts as well as North Wales all of which have plenty to offer.

Related Items

Related Items random header image

Education Home

PhD: About the Programme

Application Deadlines and Processes

Related Links

Cancer Research UK Manchester Centre

Manchester Cancer Research Centre

CRUK Lung Cancer Centre of Excellence

Download our Annual Report

Annual report download image

Cancer Research UK Manchester Institute The University of Manchester Wilmslow Road Manchester M20 4BX

Telephone 0161 306 0871 Email [email protected]

Student doing lab work

DPhil in Cancer Science

  • Entry Requirements
  • Funding and Costs

College preference

  • How to Apply

About the course

This DPhil programme is for basic science graduates, clinical students and trainee clinicians who want to undertake advanced study in the field of cancer research. The programme provides a solid grounding in the study of oncology and cancer biology through the provision of advanced level seminars in the first year and subject specific training in your host department.

As a doctoral student on the programme, you will carry out research in a single laboratory for three to four years on a full-time basis. There is no period of rotation between laboratories. All doctoral students develop their skills through a range of research training and skills development in their first year of full-time study, by attending compulsory and optional courses and lectures in laboratory techniques and generic skills, including scientific writing and statistics, while also carrying out your research project.

You will be encouraged to attend lectures and seminars related to your programme of research and make the most of the doctoral training and research methods provision available across the University. The aim is to tailor this training to individual needs and bring all students up to an advanced level in background knowledge. Later training is focused on the skills required for a successful career in independent research and for clinicians, to successful re-integration into clinical training.

This course has four different tracks and your application will be considered for the track that is most appropriate to your previous study and/or employment. Clinical trainees (track one) and medical undergraduates (track two) will enrol on a three-year programme. Non-clinical/fundamental scientists (track three and four) will enrol on a four-year programme. Students are admitted directly to work under the supervision of a Principal Investigator who is formally appointed as the DPhil supervisor. Students are based in a research group/laboratory to undertake one of the research projects advertised. 

This course provides an opportunity to join the Oxford Cancer community . DPhil students in the Cancer Science Programme at the University of Oxford are supported by a grant from Cancer Research UK, managed through the CRUK Oxford Centre.

Supervision

The allocation of graduate supervision is the responsibility of the Medical Sciences Doctoral Training Centre and it is not always possible to accommodate the preferences of incoming graduate students to work with a particular member of staff. Under exceptional circumstances a supervisor may be found outside the Medical Sciences Doctoral Training Centre.

Students on the DPhil in Cancer Science Programme are from a diverse range of backgrounds and specialisms, and study an assortment of subjects across many different departments and institutes. As such, every student-supervisor relationship is tailored to the specific needs of each. Students can expect to meet with their supervisors between every one to four weeks for input and guidance, although this may change throughout the programme as students accumulate more experience. Independent mentorship and supervision will be provided centrally form the programme and will meet one to two times per year.

Students begin the DPhil in Cancer Science programme as a probationary research student (PRS). Before the end of their fourth term, students are required to write a report prior to transfer to DPhil status. Progress is evaluated by two academic assessors, who are not directly involved in the student’s supervision. Continuation on the DPhil programme is subject to passing the Confirmation of Status assessment in year two or three. The doctoral work will culminate in a thesis that will be defended in an oral examination ( viva voce ). Students are expected to submit their thesis between the ninth and twelfth terms from being admitted as a PRS.

Graduate destinations

DPhil in Cancer Science was a new course for entry in 2020, but historically, postgraduate cancer research students follow a wide variety of career paths, including all branches of biomedical research, clinical medicine, teaching, health administration and commerce. Further information about alumni destinations for cancer research students can be found on the Oxford Cancer website.

Changes to this course and your supervision

The University will seek to deliver this course in accordance with the description set out in this course page. However, there may be situations in which it is desirable or necessary for the University to make changes in course provision, either before or after registration. The safety of students, staff and visitors is paramount and major changes to delivery or services may have to be made in circumstances of a pandemic, epidemic or local health emergency. In addition, in certain circumstances, for example due to visa difficulties or because the health needs of students cannot be met, it may be necessary to make adjustments to course requirements for international study.

Where possible your academic supervisor will not change for the duration of your course. However, it may be necessary to assign a new academic supervisor during the course of study or before registration for reasons which might include illness, sabbatical leave, parental leave or change in employment.

For further information please see our page on changes to courses and the provisions of the student contract regarding changes to courses.

Entry requirements for entry in 2024-25

Proven and potential academic-experience.

The degree-level qualifications that are required for this course vary according to the application type:

Degree-level qualifications for clinical trainees (Application type 1)

The requirements below apply to qualified doctors at all stages of training from the foundation training to higher specialist training. 

As a minimum, applicants should hold or be predicted to achieve the equivalent of the following UK qualifications:

  • a first-class or strong upper second-class undergraduate degree with honours  in a relevant discipline such as biology, biochemistry, or medicine.

However, entrance is very competitive and most successful applicants have a first-class degree or the equivalent.

A previous master's degree is not required.

For applicants with a degree from the USA, the minimum GPA sought is 3.5 out of 4.0.

If your degree is not from the UK or another country specified above, visit our International Qualifications page for guidance on the qualifications and grades that would usually be considered to meet the University’s minimum entry requirements.

Degree-level qualifications for medical undergraduate students (Application type 2)

The requirements below apply to medical undergraduate students.

Medical students who are currently undertaking a primary medical qualification (MBBS, MBChB or equivalent)

At entry (with the exception of Medical students currently at Oxford, see below), applicants should provide evidence of successful completion of at least the first two years of a primary medical qualification and should hold or be predicted to achieve the equivalent of the following UK qualifications:

Medical students currently at Oxford

Medical students currently at Oxford should have successfully completed the Pre-clinical Course (First BM) and hold or be predicted to achieve:

  • a first class or strong upper second-class BA Honours in Medical Sciences.

All medical undergraduate students

Entrance is expected to be very competitive and it is anticipated that most successful applicants have a first-class degree or the equivalent.

Degree-level qualifications for non-clinical/fundamental scientists (Application type 3)

The requirements below apply to science graduates.

  • a first-class or strong upper second-class undergraduate degree with honours in a biological, medical, chemical, mathematical and physical science background, as appropriate for the projects offered.  

However, entrance is expected to be very competitive and it is anticipated that most successful applicants have a first-class degree or the equivalent.

GRE General Test scores

No Graduate Record Examination (GRE) or GMAT scores are sought.

Other qualifications, evidence of excellence and relevant experience

  • Evidence of a prior interest in the area of research proposed is likely to advantage your application.
  • Prior publications are not required, but research experience and a track record demonstrating an interest in research may be an advantage.
  • It would be expected that graduate applicants would be familiar with the recent published work of their proposed supervisor.
  • Commitment to and passion for a career in cancer research.
  • Reasoning ability and academic curiosity.

English language proficiency

This course requires proficiency in English at the University's  standard level . If your first language is not English, you may need to provide evidence that you meet this requirement. The minimum scores required to meet the University's standard level are detailed in the table below.

*Previously known as the Cambridge Certificate of Advanced English or Cambridge English: Advanced (CAE) † Previously known as the Cambridge Certificate of Proficiency in English or Cambridge English: Proficiency (CPE)

Your test must have been taken no more than two years before the start date of your course. Our Application Guide provides further information about the English language test requirement .

Declaring extenuating circumstances

If your ability to meet the entry requirements has been affected by the COVID-19 pandemic (eg you were awarded an unclassified/ungraded degree) or any other exceptional personal circumstance (eg other illness or bereavement), please refer to the guidance on extenuating circumstances in the Application Guide for information about how to declare this so that your application can be considered appropriately.

You will need to register three referees who can give an informed view of your academic ability and suitability for the course. The  How to apply  section of this page provides details of the types of reference that are required in support of your application for this course and how these will be assessed.

Supporting documents

You will be required to supply supporting documents with your application. The  How to apply  section of this page provides details of the supporting documents that are required as part of your application for this course and how these will be assessed.

Performance at interview

Interviews are normally held as part of the admissions process.  

Candidates who are shortlisted are interviewed as part of the admissions process. Shortlisting will be based solely on the criteria given above. There will be a minimum of two to three academics on the interview panel. By preference, interviews will be conducted in person, but when this is not possible we will use telephone or video link such as Zoom (with video) and ensure that applicants are not disadvantaged by using these forms of communication.  Normally the interview will consist of a five-minute presentation of previous project work by the applicant, followed by 15-25 minutes of questioning from the panel.

How your application is assessed

Your application will be assessed purely on your proven and potential academic excellence and other entry requirements described under that heading.

References  and  supporting documents  submitted as part of your application, and your performance at interview (if interviews are held) will be considered as part of the assessment process. Whether or not you have secured funding will not be taken into consideration when your application is assessed.

An overview of the shortlisting and selection process is provided below. Our ' After you apply ' pages provide  more information about how applications are assessed . 

Shortlisting and selection

Students are considered for shortlisting and selected for admission without regard to age, disability, gender reassignment, marital or civil partnership status, pregnancy and maternity, race (including colour, nationality and ethnic or national origins), religion or belief (including lack of belief), sex, sexual orientation, as well as other relevant circumstances including parental or caring responsibilities or social background. However, please note the following:

  • socio-economic information may be taken into account in the selection of applicants and award of scholarships for courses that are part of  the University’s pilot selection procedure  and for  scholarships aimed at under-represented groups ;
  • country of ordinary residence may be taken into account in the awarding of certain scholarships; and
  • protected characteristics may be taken into account during shortlisting for interview or the award of scholarships where the University has approved a positive action case under the Equality Act 2010.

Initiatives to improve access to graduate study

This course is taking part in a continuing pilot programme to improve the selection procedure for graduate applications, in order to ensure that all candidates are evaluated fairly.

For this course, socio-economic data (where it has been provided in the application form) will be used to contextualise applications at the different stages of the selection process.  Further information about how we use your socio-economic data  can be found in our page about initiatives to improve access to graduate study.

Processing your data for shortlisting and selection

Information about  processing special category data for the purposes of positive action  and  using your data to assess your eligibility for funding , can be found in our Postgraduate Applicant Privacy Policy.

Admissions panels and assessors

All recommendations to admit a student involve the judgement of at least two members of the academic staff with relevant experience and expertise, and must also be approved by the Director of Graduate Studies or Admissions Committee (or equivalent within the department).

Admissions panels or committees will always include at least one member of academic staff who has undertaken appropriate training.

Other factors governing whether places can be offered

The following factors will also govern whether candidates can be offered places:

  • the ability of the University to provide the appropriate supervision for your studies, as outlined under the 'Supervision' heading in the  About  section of this page;
  • the ability of the University to provide appropriate support for your studies (eg through the provision of facilities, resources, teaching and/or research opportunities); and
  • minimum and maximum limits to the numbers of students who may be admitted to the University's taught and research programmes.

Offer conditions for successful applications

If you receive an offer of a place at Oxford, your offer will outline any conditions that you need to satisfy and any actions you need to take, together with any associated deadlines. These may include academic conditions, such as achieving a specific final grade in your current degree course. These conditions will usually depend on your individual academic circumstances and may vary between applicants. Our ' After you apply ' pages provide more information about offers and conditions . 

In addition to any academic conditions which are set, you will also be required to meet the following requirements:

Financial Declaration

If you are offered a place, you will be required to complete a  Financial Declaration  in order to meet your financial condition of admission.

Disclosure of criminal convictions

In accordance with the University’s obligations towards students and staff, we will ask you to declare any  relevant, unspent criminal convictions  before you can take up a place at Oxford.

Academic Technology Approval Scheme (ATAS)

Some postgraduate research students in science, engineering and technology subjects will need an Academic Technology Approval Scheme (ATAS) certificate prior to applying for a  Student visa (under the Student Route) . For some courses, the requirement to apply for an ATAS certificate may depend on your research area.

As a student on this course you will have access to experimental facilities, as appropriate to your research. IT support will be provided from both the department hosting your research and University IT Services. You will also have access to library services such as the Radcliffe Science Library and the Cairns Library.

The provision of project-specific resources will be agreed with the relevant supervisor and host department during the planning stages for the research project. You will be based in various units, buildings and campuses around Oxford with the department supporting a wide range of clinical services located in Oxford’s John Radcliffe and Churchill Hospitals.

The Oxford Cancer team provide an induction to the programme in the first weeks of study and encourages attendance at divisional and University induction events.

Workspace will be allocated according to individual circumstances. If undertaking experimental work, you will be provided with bench space in a laboratory. If undertaking theoretical research, you will have shared office space.

Medical Sciences Doctoral Training Centre

The Medical Sciences Doctoral Training Centre (MSDTC) accommodates the interdisciplinary, cross-departmental DPhil programmes in medical sciences.

Most are structured DPhil programmes, which provide students with the opportunity to undertake two or three 'rotation' projects and relevant course work in their first year of each four-year structured programme. The main doctoral project starts in the second year of each programme. Most of our programmes receive external core-funding, and currently from the Wellcome Trust (WT), British Heart Foundation, Cancer Research UK and EPSRC.

The MSDTC also accommodates the NIH Oxford-Cambridge Scholars’ Programme, the DPhil in Cancer Science programme funded by CRUK which welcomes applications from clinicians, basic scientists, and medical undergraduates, and the new DPhil in Inflammatory and Musculoskeletal Disease which is funded by the Kennedy Trust for Rheumatology Research and is open to Oxford University medical students wishing to undertake DPhils in the fields of musculoskeletal disease, inflammation and immunology.

The department also offers an exciting new programme (the DPhil in Advanced Bioscience of Viral Products) run in collaboration with Oxford Biomedica, which aims to deliver the next generation of bioscience leaders to advance research on the underpinning bioscience of viral products for future gene therapies and vaccines.

Each programme has a distinctive intellectual flavour, designed to nurture independent and creative scientists. Students are supported in their development through:

  • supervision and mentoring by world-class academics training in a wide range of research techniques
  • development of student resilience and maintenance of mental health and wellbeing from the start and throughout each programme.

View all courses   View taught courses View research courses

The University expects to be able to offer over 1,000 full or partial graduate scholarships across the collegiate University in 2024-25. You will be automatically considered for the majority of Oxford scholarships , if you fulfil the eligibility criteria and submit your graduate application by the relevant December or January deadline. Most scholarships are awarded on the basis of academic merit and/or potential. 

For further details about searching for funding as a graduate student visit our dedicated Funding pages, which contain information about how to apply for Oxford scholarships requiring an additional application, details of external funding, loan schemes and other funding sources.

Please ensure that you visit individual college websites for details of any college-specific funding opportunities using the links provided on our college pages or below:

Please note that not all the colleges listed above may accept students on this course. For details of those which do, please refer to the College preference section of this page.

Medical students currently at Oxford should refer to the funding advice available on the Oxford Students website. You will need to select the six-year course and refer to the information provided under 'Studying for a higher degree'.

Further information about funding opportunities for this course can be found on the department's website.

Annual fees for entry in 2024-25

Further details about fee status eligibility can be found on the fee status webpage.

Information about course fees

Course fees are payable each year, for the duration of your fee liability (your fee liability is the length of time for which you are required to pay course fees). For courses lasting longer than one year, please be aware that fees will usually increase annually. For details, please see our guidance on changes to fees and charges .

Course fees cover your teaching as well as other academic services and facilities provided to support your studies. Unless specified in the additional information section below, course fees do not cover your accommodation, residential costs or other living costs. They also don’t cover any additional costs and charges that are outlined in the additional information below.

Continuation charges

Following the period of fee liability , you may also be required to pay a University continuation charge and a college continuation charge. The University and college continuation charges are shown on the Continuation charges page.

Where can I find further information about fees?

The Fees and Funding  section of this website provides further information about course fees , including information about fee status and eligibility  and your length of fee liability .

Additional information

There are no compulsory elements of this course that entail additional costs beyond fees (or, after fee liability ends, continuation charges) and living costs. However, please note that, depending on your choice of research topic and the research required to complete it, you may incur additional expenses, such as travel expenses, research expenses, and field trips. You will need to meet these additional costs, although you may be able to apply for small grants from your department and/or college to help you cover some of these expenses.

Living costs

In addition to your course fees, you will need to ensure that you have adequate funds to support your living costs for the duration of your course.

For the 2024-25 academic year, the range of likely living costs for full-time study is between c. £1,345 and £1,955 for each month spent in Oxford. Full information, including a breakdown of likely living costs in Oxford for items such as food, accommodation and study costs, is available on our living costs page. The current economic climate and high national rate of inflation make it very hard to estimate potential changes to the cost of living over the next few years. When planning your finances for any future years of study in Oxford beyond 2024-25, it is suggested that you allow for potential increases in living expenses of around 5% each year – although this rate may vary depending on the national economic situation. UK inflationary increases will be kept under review and this page updated.

Students enrolled on this course will belong to both a department/faculty and a college. Please note that ‘college’ and ‘colleges’ refers to all 43 of the University’s colleges, including those designated as societies and permanent private halls (PPHs). 

If you apply for a place on this course you will have the option to express a preference for one of the colleges listed below, or you can ask us to find a college for you. Before deciding, we suggest that you read our brief  introduction to the college system at Oxford  and our  advice about expressing a college preference . For some courses, the department may have provided some additional advice below to help you decide.

If you are a current Oxford medical student and you would like to remain at your current Oxford college, you should check the list below to see whether it accepts applications for the course to which you are applying. If it does, you can indicate this preference when you apply. If it does not, please refer to the instructions in our application guide under the heading ' Can I stay at my current Oxford college? '.

The following colleges accept students on the DPhil in Cancer Science:

  • Balliol College
  • Green Templeton College
  • Hertford College
  • Lady Margaret Hall
  • Linacre College
  • New College
  • Reuben College
  • St Anne's College
  • St Catherine's College
  • St Cross College
  • St Hilda's College
  • St Hugh's College
  • St John's College
  • University College
  • Wycliffe Hall

Before you apply

We strongly recommend you consult the Medical Sciences Graduate School's research themes to identify the most suitable course and supervisor .

Our  guide to getting started  provides general advice on how to prepare for and start your application. Check the deadlines on this page and the information about deadlines  in our Application Guide. If it's important for you to have your application considered under a particular deadline – eg under a December or January deadline in order to be considered for Oxford scholarships – we recommend that you aim to complete and submit your application at least two weeks in advance .

Application fee waivers

An application fee of £75 is payable per course application. Application fee waivers are available for the following applicants who meet the eligibility criteria:

  • applicants from low-income countries;
  • refugees and displaced persons; 
  • UK applicants from low-income backgrounds; and 
  • applicants who applied for our Graduate Access Programmes in the past two years and met the eligibility criteria.

You are encouraged to  check whether you're eligible for an application fee waiver  before you apply.

Readmission for current Oxford graduate taught students

If you're currently studying for an Oxford graduate taught course and apply to this course with no break in your studies, you may be eligible to apply to this course as a readmission applicant. The application fee will be waived for an eligible application of this type. Check whether you're eligible to apply for readmission .

Application fee waivers for eligible associated courses

If you apply to this course and up to two eligible associated courses from our predefined list during the same cycle, you can request an application fee waiver so that you only need to pay one application fee.

The list of eligible associated courses may be updated as new courses are opened. Please check the list regularly, especially if you are applying to a course that has recently opened to accept applications.

Do I need to contact anyone before I apply?

It is strongly recommended that you contact potential supervisors directly to discuss the advertised project(s) in the  DPhil Projects Book  (which can be accessed via the course page on the Oxford Cancer website) before you apply. 

If you have any general course enquiries, these can be directed to the course administrator using the contact details provided on this page. 

Completing your application

You should refer to the information below when completing the application form, paying attention to the specific requirements for the supporting documents .

For this course, the application form will include questions that collect information that would usually be included in a CV/résumé. You should not upload a separate document. If a separate CV/résumé is uploaded, it will be removed from your application .

If any document does not meet the specification, including the stipulated word count, your application may be considered incomplete and not assessed by the academic department. Expand each section to show further details.

Proposed field and title of research project

Proposed supervisor.

Under 'Proposed supervisor name' enter the name of the academic(s) who you would like to supervise your research. 

You may name up to three proposed supervisors and rank these in order of preference.

Referees: Three overall, academic preferred

Whilst you must register three referees, the department may start the assessment of your application if two of the three references are submitted by the course deadline and your application is otherwise complete. Please note that you may still be required to ensure your third referee supplies a reference for consideration.

Academic references are strongly encouraged, though you may use up to one professional reference provided that it is relevant to the course.

Your references will support intellectual ability, academic achievement, motivation and ability to work in a group.

Official transcript(s): Required for all applications. Medical undergraduate students also require a letter of permission.

Your transcripts should give detailed information of the individual grades received in your university-level qualifications to date. You should only upload official documents issued by your institution and any transcript not in English should be accompanied by a certified translation.

More information about the transcript requirement is available in the Application Guide.

Statement of purpose/personal statement: A maximum of 500 words

You should provide a statement of your research interests, in English, describing how your background and research interests relate to the programme. If possible, please ensure that the word count is clearly displayed on the document.

The statement should focus on academic or research-related achievements and interests rather than personal achievements and interests.

This will be assessed for:

  • your reasons for applying;
  • evidence of motivation for and understanding of the proposed area of study;
  • the ability to present a reasoned case in English;
  • capacity for sustained and focused work; and
  • understanding of problems in the area and ability to construct and defend an argument.

It will be normal for students’ ideas and goals to change in some ways as they undertake their studies, but your personal statement will enable you to demonstrate your current interests and aspirations.

Start or continue your application

You can start or return to an application using the relevant link below. As you complete the form, please  refer to the requirements above  and  consult our Application Guide for advice . You'll find the answers to most common queries in our FAQs.

Application Guide   Apply

ADMISSION STATUS

Closed to applications for entry in 2024-25

Register to be notified via email when the next application cycle opens (for entry in 2025-26)

12:00 midday UK time on:

Friday 1 December 2023 Latest deadline for most Oxford scholarships

A later deadline shown under 'Admission status' If places are still available,  applications may be accepted after 1 December . The 'Admissions status' (above) will provide notice of any later deadline.

*Three-year average (applications for entry in 2021-22 and 2023-24)

Further information and enquiries

This course is offered by the Medical Sciences Doctoral Training Centre

  • Course page on the Oxford Cancer website
  • Course page on the Medical Sciences website
  • Funding information from Medical Sciences
  • Research staff
  • Divisional research
  • Medical Sciences Graduate School
  • Residence requirements for full-time courses
  • Postgraduate applicant privacy policy

Course-related enquiries

Advice about contacting the department can be found in the How to apply section of this page

[email protected] ☎ +44 (0)1865 289548

Application-process enquiries

See the application guide

Other courses to consider

You may also wish to consider applying to other courses that are similar or related to this course:

View related courses

Cancer & Pharmaceutical Sciences MPhil/PhD MD/(Res)

IPS students

Key information

The School of Cancer and Pharmaceutical Sciences comprises of the Comprehensive Cancer Centre (CCC), Institute of Pharmaceutical Sciences (IPS) and recently incorporated Analytical, Environmental & Forensic Sciences Department.

Within the Comprehensive Cancer Centre there are thirteen research programmes and 20 research groups.

The Institute of Pharmaceutical Science has three main research themes of Drug Discovery; Medicines Development and Delivery; and Medicines Use. Find out more about the Institute of Pharmaceutical Science and view current opportunities .

Discover more about the Analytical, Environmental & Forensic Sciences department here .

We collaborate extensively with scientists and clinicians across KCL and within King’s Health Partners (KHP ).

The overarching objective of the Comprehensive Cancer Centre is to combine research excellence with innovations in clinical practice to improve cancer patient care and therefore our research goes from basic biological research through to translational cancer research to clinical trials. We have a particular focus on tumour microenvironment, imaging and immunotherapy, which are the themes of our Cancer Research UK King's Health Partners' Cancer Centre'.

Each of the three themes within IPS includes clusters of research activity, some of which have evolved during the past decade ( e.g., drug delivery, chemical biology, pharmaceutical biophysics, pharmacology), and some of which have joined KCL more recently such as enhanced activity in anticancer and anti-infective drug discovery, nanomedicines, substance abuse, health psychology, and clinical pharmacy. Researchers within and across the three themes interact both informally and via joint initiatives to promote cross-disciplinary research.

Please visit the School of Cancer & Pharmaceutical Sciences for further information. 

Head of group/division

Professor Tony Ng and Professor Ben Forbes

Studentships

Our studentships are regularly advertised on Find A PhD and Funding Opportunities webpages.

  • How to apply
  • Fees or Funding

UK Tuition Fees 2023/24

Full time tuition fees:

£6,540 per year (MPhil/PhD)

£6,540 per year (MPhil/PhD Clinical)

£6,540 per year (MDRes Clinical)

Part time tuition fees:

£3,300 per year (MPhil/PhD)

£3,300 per year (MPhil/PhD Clinical)

£3,300 per year (MDRes Clinical)

International Tuition Fees 2023/24

£28,740 per year (MPhil/PhD)

£54,660 per year (MPhil/PhD Clinical)

£54,660 per year (MDRes Clinical)

£14,310 per year (MPhil/PhD)

£27,360 per year (MPhil/PhD Clinical)

£27,360 per year (MDRes Clinical)

UK Tuition Fees 2024/25

£6,936 per year (MPhil/PhD)

£6,936 per year (MPhil/PhD Clinical)

£6,936 per year (MDRes Clinical)

£3,468 per year (MPhil/PhD)

£3,468 per year (MPhil/PhD Clinical)

£3,468 per year (MDRes Clinical)

International Tuition Fees 2024/25

£30,240 per year (MPhil/PhD)

£58,470 per year (MPhil/PhD Clinical)

£58,470 per year (MDRes Clinical)

£15,120 per year (MPhil/PhD)

£29,235 per year (MPhil/PhD Clinical)

£29,235 per year (MDRes Clinical)

These tuition fees may be subject to additional increases in subsequent years of study, in line with King's terms and conditions.

  • Study environment

Base campuses

NEV-main-Denmark-Hill-Campus

Denmark Hill Campus

Home to the Institute of Psychiatry, Psychology & Neuroscience

campus guys

Guy’s Campus

The Faculty of Life Sciences & Medicine and the Faculty of Dentistry, Oral & Craniofacial Sciences are based at the riverside Guy's Campus, next to the Shard.

waterloo-banner

Waterloo Campus

Waterloo campus is home of the Florence Nightingale Faculty of Nursing & Midwifery and facilities for other faculties

Students work alongside researchers and are supervised by two members of academic staff. Each student has a dedicated Thesis Progression Committee that monitors the students’ progress and gives advice and support.

Postgraduate training

KCL offers a large number of training and skills development opportunities. Participation in the annual Postgraduate Research Symposium is compulsory for all students and provides an opportunity to improve science communication and presentation skills. Opportunities are available for postgraduate students to present their work at national and international scientific meetings. Our postgraduate students also have the opportunity to assist with teaching of undergraduates as demonstrators in practical classes or by leading tutorials.

  • Entry requirements

phd cancer uk

Find a supervisor

Search through a list of available supervisors.

For enquiries please contact the email addresses below

phd cancer uk

School of Cardiovascular and Metabolic Medicine & Sciences

Research and Impact at the School of Cardiovascular and Metabolic...

phd cancer uk

Studentship Funding Opportunities

View funded studentships currently available

phd cancer uk

Connect with a King’s Advisor

Want to know more about studying at King's? We're here to help.

phd cancer uk

Learning in London

King's is right in the heart of the capital.

Recommended pages

  • Undergraduate open days
  • Postgraduate open days
  • Accommodation
  • Information for teachers
  • Maps and directions
  • Sport and fitness

Cancer Research UK Clinical PhDs at the University of Birmingham

A prestigious Cancer Research UK Clinical Academic Training Programme, led by  Professor Gary Middleton , offering fully funded clinical PhD fellowships, aligned with our cancer focused research from the  Institute of Cancer & Genomic Sciences , the  Institute of Immunology & Immunotherapy  and the  Institute of Metabolism and Systems Research . 

Scientist using a pipette

Awarded in April 2019, the Cancer Research UK Clinical Academic Training Programme in Birmingham will fund 10 Clinical Research Training Fellowships and eight Intercalated MBPhD studentships over five years.

We aim to be a leading centre for the development of the next generation of academic clinicians and clinician scientists working towards curing cancer. We want at least 20% of our consultant workforce in oncology to be academic clinicians and for every multidisciplinary team to have an academic clinician as a core member.

Why does this matter? View the below video to find out what clinical research and trials mean to patients.

Our Cancer Research UK Clinical Academic Training Programme provides an outstanding opportunity for early career training in a dynamic, multidisciplinary environment, and is committed to delivering and strengthening a holistic training pathway, from Masters’ level to mid-stage career researcher.

In addition, delivery of high quality research outputs from these studentships, including high impact publications, novel therapeutic strategies and clinical trial concepts, are viewed as strategically important for the development of translational cancer research in Birmingham.

Kick-start your career at the University of Birmingham as a clinical PhD fellow and help to make it one of the UK’s most successful sites for translationally oriented cancer research.

Studentship details

Funding: Please note that fees are only funded up to UK Home rate, and any difference will need to be self-funded.

Clinical Research Training Fellowships

  • Up to £265,000 over three years, including fees, laboratory running expenses (~£13,500 per year) and salary.  
  • First or Upper Second Class Honours Degree in a relevant subject, plus some experience of working in a laboratory is required. Additionally this opportunity is only appropriate to applicants with a medical degree, that are currently undertaking clinical training and are expected to return to clinical training in the UK following completion of the PhD.

Intercalating MBPhDs

  • Three-year studentships provide full funding for PhD tuition fees, laboratory running expenses (~£13,500 per year) and stipend (£21,000 per year). 
  • This opportunity is currently only open to students studying at the University of Birmingham. Applicants should have completed at least two years of an MBChB or one year of the Graduate Entry Medicine (GEM) course. Applicants should also have completed or be completing an intercalating degree, or for GEM students only, have completed an undergraduate degree in a relevant subject.

Funding note: Fees are only funded up to UK Home rate, and any difference will need to be self-funded.

Scientific focus

Projects cover the three core themes of Immunology, Genomics and the Tumour Microenvironment.

How to apply

The 2024 application process is now open. Application deadline is 8 th April 2024. 

Leadership and Governance

Find out who the members are for our Clinical Academic Training Programme Management Group. 

Our student cohort

Find out more about our recent graduates and current student cohort.

CRUK Clinical Academic Training Programme - Student Outputs and Achievements 2019 - 2024

""

Culture and collections

phd cancer uk

Schools, institutes and departments

College of arts and law.

  • Birmingham Law School
  • English, Drama and Creative Studies
  • History and Cultures
  • Language, Cultures, Art History and Music
  • Philosophy, Theology and Religion

College of Medical and Dental Sciences

  • Applied Health Research
  • Biomedical Science
  • Birmingham Medical School
  • Cancer and Genomic Sciences
  • Cardiovascular Sciences
  • Clinical Sciences
  • Graduate School
  • Immunology and Immunotherapy
  • Inflammation and Ageing
  • Metabolism and Systems Research
  • Microbiology and Infection
  • Nursing and Midwifery

College of Life and Environmental Sciences

  • Biosciences
  • Geography, Earth and Environmental Sciences
  • Sport, Exercise and Rehabilitation Sciences

College of Engineering and Physical Sciences

  • Chemical Engineering
  • Computer Science
  • Engineering
  • Mathematics
  • Metallurgy and Materials
  • Physics and Astronomy

College of Social Sciences

  • Birmingham Business School
  • Social Policy

See all schools, departments, research and professional services

  • Liberal Arts and Natural Sciences

Services and facilities

  • Conferences and Events
  • The Exchange
  • Birmingham Day Nurseries
  • Guild of students
  • Facilities search
  • University of Birmingham School
  • UoB Sport and Fitness
  • Online Shop
  • Freedom of Speech
  • Accessibility
  • Canvas Learning Environment
  • Publication Scheme
  • Information for Applicants
  • Freedom of information
  • Charitable information
  • Cookies and cookie policy
  • Website feedback
  • Current Students
  • News & Press
  • Research Excellence
  • Teaching & Student Experience
  • Graduate Employability
  • UK Rankings
  • World Rankings
  • Single Topic Rankings
  • Research Excellence Framework
  • Higher Education Awards
  • Ageing and Health
  • Cities and Place
  • Culture and Creative Arts
  • Faculty of Science, Agriculture & Engineering
  • Faculty of Humanities & Social Sciences
  • Faculty of Medical Sciences
  • Social Justice
  • Central and South Asia
  • Latin America
  • Middle East and North Africa
  • North America
  • Small Island Developing States
  • South East Asia and Oceania
  • Sub-Saharan Africa
  • Erasmus Policy Statement
  • Transparency
  • Office for Students Transparency Data
  • Access & Participation
  • UN Sustainable Development Goals
  • https://www.ncl.ac.uk/who-we-are/equality/race-equality/black-history-month/
  • Faith, Religion & Belief
  • Lesbian, Gay, Bisexual & Transgender
  • Let Us Know
  • Workplace Adjustments
  • Useful Resources
  • Equality Analysis
  • Social Justice Stories
  • Voluntary & Community Groups
  • Santander Universities
  • Regional Partnerships
  • Widening Participation
  • Newcastle Helix
  • Art on Campus
  • History of Newcastle University
  • Find a Degree
  • Subject Areas
  • Step-by-Step Guide for UK Students
  • Step-by-Step Guide for International & EU Students
  • Applying through UCAS
  • A and AS Levels
  • Application Decisions
  • Access Schemes & Pathway Programmes
  • Policies & Procedures
  • Applicants with Disabilities
  • Mature Applicants
  • Deferred Entry
  • Undergraduate Application Advice
  • Subject Scholarships
  • Sports Scholarships
  • Opportunity Scholarships
  • VC's Excellence Scholarships
  • VC's Global Scholarships
  • VC's International Scholarships
  • International Foundation Scholarships
  • St Nicholas’ Educational Trust Scholarship
  • NU Sanctuary Scholarships
  • Undergraduate Norway Scholarship
  • International Family Discounts
  • VC’s EU Scholarships – Undergraduate
  • VC's Excellence Scholarships - Europe
  • VC's Business Excellence Scholarships - Europe
  • Cowrie Foundation Scholarship
  • Edward Long Scholarship
  • Alumni Discount
  • Different Tuition Fees
  • Additional Costs
  • Student Loans
  • International Student Finance
  • Sign up & Discover
  • Why Choose Newcastle?
  • Your Study Options
  • Qualifications Explained
  • Postgraduate Research Programmes
  • Search for Funding
  • Guide to Funding
  • Postgraduate Tuition Fees
  • Application Help
  • Advice & Resources
  • Your Offer Guide
  • Postgraduate Open Days
  • Doctoral College
  • Distance Learning
  • Continuing Professional Development (CPD)
  • Study Support
  • Campus Tours
  • Life in Newcastle
  • Get Involved
  • Cost of Living
  • Health & Wellbeing
  • Mature Students
  • Childcare Support
  • Care Leavers
  • Asylum Seekers
  • Teaching & Learning
  • Student Blog - Belong
  • Types of Accommodation
  • Types of Rooms
  • Catering Options
  • How to Choose
  • Our Promise to You
  • New Student Guarantee
  • How to Apply
  • What Happens Next?
  • Arrival Information
  • For Undergraduates
  • For Postgraduates
  • For Couples & Families
  • Accessible Accommodation
  • Payment in Full
  • Direct Debit
  • Managed Partnerships
  • Reporting a Fault
  • Room Changes
  • Safety & Security
  • Energy & Recycling
  • Parking & Bicycle
  • Summer Extensions
  • Returning Next Year
  • Staff & Visitors
  • Useful Information
  • Work Placements
  • About the Careers Service
  • Careers Service News
  • Careers Service Events
  • Work for Yourself
  • Career Planning
  • Careers Modules
  • Making Applications
  • Interviews, Tests & Assessment Centres
  • Internships, Placements & Shadowing
  • Finding Jobs
  • Handling Job Offers
  • Researching Employers
  • Making Contacts
  • Further Study
  • Awards, Competitions & Project Funding
  • Volunteering
  • Boost Your CV
  • Defence Technical Undergraduate Scheme (DTUS)
  • Getting Here
  • Self-Guided Campus Tours
  • Undergraduate Offer Holder Days
  • Postgraduate Schools & Supervisors
  • Undergraduate Open Days
  • Tier 4 Visa from Inside UK
  • Tier 4 Visa from Outside UK
  • Short-Term Visa from Outside UK
  • International Study Blog
  • Our Pathway Courses
  • English Language Courses
  • Fees, Costs and Scholarships
  • INTO Newcastle University
  • Student Exchange and Study Abroad
  • Request a Prospectus
  • Chat to a Student
  • Your Academic Experience
  • Research Impact
  • Research Strengths
  • Centres of Research Excellence
  • Research Culture Action Plan
  • Working Together on Research Culture
  • Policy Notes
  • Global Partnerships
  • Let's Work Together
  • Sustainable Water
  • Food Security
  • Sustainable Livelihoods
  • Global Impact
  • Research Excellence Framework (REF) 2021
  • Code of Good Practice in Research
  • University Research Committee
  • Animal Research Policy
  • Declaration on Openness on Animal Research
  • Animal Procedures
  • Helping Human Health
  • Animal Research News
  • Ethics at Newcastle
  • Research Data and Open Access
  • Research Strategy & Development
  • Policy and Information Team
  • Grants & Contracts (HaSS and SAgE)
  • NJRO (inc Grants & Contracts FMS)
  • Research Funding Development
  • Biomedical Facilities
  • Chemistry Facilities
  • Clinical Facilities
  • Engineering Facilities
  • Marine & Agricultural Facilities
  • More Facilities
  • Facilities A to Z
  • Research Funding
  • Research News
  • Case Studies
  • CPD Courses
  • Collaborative Research
  • Company Creation
  • Consultancy
  • Corporate Partnerships
  • DA Power Engineering
  • DA MSc Digital Technology Solutions
  • DA Executive Education Snr. Leader Apprenticeships
  • Facilities and Equipment
  • Intensive Industrial Innovation Programme
  • Knowledge Transfer Partnerships
  • Technology Transfer and Licensing
  • Clinical Trials & Research
  • Working with Newcastle
  • Tender Opportunities
  • Submitting an Invoice
  • Sustainable Procurement
  • Code of Conduct & Policies
  • Meet the Team
  • Business and Partnerships
  • Connect with alumni
  • Develop your career
  • Discover lifelong learning opportunities
  • Support future generations

Cancer MPhil, PhD, MD

We're a major training base for the next generation of cancer researchers. Clinicians, scientists and students engaged in cancer research at Newcastle share a common purpose: to improve treatment outcomes for patients with cancer.

You are currently viewing course information for entry year:

Start date(s):

  • September 2024
  • January 2025

Our staff and postgraduate students work in the Faculty of Medical Sciences or in the School of Natural and Environmental Sciences . The NICR incorporates the Newcastle Cancer Centre. This is a unique collaboration between Cancer Research UK and the North of England Children's Cancer Research Fund.

Work covers a broad spectrum:

  • understanding the biological differences between normal and malignant cells
  • understanding the molecular differences between normal and malignant cells
  • using this knowledge to develop new anti-cancer drugs

We're a major training base for the next generation of cancer researchers. Our Institute covers many areas of cancer research, including:

  • solid tumours and leukaemias
  • childhood and adult cancers
  • drug discovery and early phase clinical trials

Molecular genetic and mechanistic studies identify critical molecular changes in cancer. It identifies the relevance to disease development and progression. We use these biomarkers and targets for therapeutic intervention. We use a wide range of techniques, including:

  • contemporary genomic
  • bioinformatic
  • molecular biology
  • biochemical
  • cell biology

Studies focus on:

  • haematological malignancies (leukaemia and lymphoma)
  • paediatric solid tumours (neuroblastoma and medulloblastoma),
  • adult solid tumours (eg breast, ovarian, prostate, bladder and liver cancers).

We exploit critical molecular defects as biomarkers to enhance:

  • disease detection and diagnosis
  • prediction of disease course
  • sensitivity to specific drugs
  • therapeutic monitoring.

We play leading roles in molecular diagnostics, biomarker assessment and therapeutic monitoring. This is for national and international clinical trials.

The use of rational drug design helps achieve the exploitation of novel targets. It is through the use of structure-based design, in conjunction with medium-throughout screening. Target molecule synthesis and varied parallel synthesis approaches result in lead optimisation. Candidate drugs undergo evaluation in cell-free and whole-cell target-based assays.

Clinical trials (Phase I/II/III) are undertaken in both adults and children. Trials have a strong hypothesis-testing translational research component. They are performed under:

  • national or international research networks (eg CR–UK, Children's Cancer
  • Leukaemia Group, European Organisation for Research and Treatment of Cancer)
  • in collaboration with the pharmaceutical industry

We are one of the few academic centres in the UK able to undertake this specialist cancer research. We achieve this through:

  • our expert staff
  • state of the art facilities
  • close working relationships with the pharmaceutical and biotechnology sectors
  • clinical trials networks

We offer approximately 15 MD, PhD and integrated MRes/PhD studentships each year. This includes the Newcastle Cancer Centre training programme. Projects in all research areas are available to fully-funded international students.

Members of our postgraduate community come from a variety of subject backgrounds. This includes:

  • biological and biomedical sciences
  • veterinary medicine

Important information

We've highlighted important information about your course. Please take note of any deadlines.

Please rest assured we make all reasonable efforts to provide you with the programmes, services and facilities described. However, it may be necessary to make changes due to significant disruption, for example in response to Covid-19.

View our  Academic experience page , which gives information about your Newcastle University study experience for the academic year 2023-24.

See our  terms and conditions and student complaints information , which gives details of circumstances that may lead to changes to programmes, modules or University services.

Related courses

Qualifications explained.

Find out about the different qualification options for this course.

An MPhil is available in all subject areas. You receive research training and undertake original research leading to the completion of a 40,000 - 50,000 word thesis.

Find out about different types of postgraduate qualifications .

A PhD is a doctorate or doctoral award. It involves original research that should make a significant contribution to the knowledge of a specific subject. To complete the PhD you will produce a substantial piece of work (80,000 – 100,000 words) in the form of a supervised thesis. A PhD usually takes three years full time.

Find out about different types of postgraduate qualifications

An MD is a doctorate or doctoral award. It combines your research findings with clinical practice. To complete the MD you will produce a substantial piece of work (80,000 – 100,000 words) in the form of a supervised thesis. For professionally qualified doctors, an MD (Doctor of Medicine) is awarded. 

How you'll learn

Depending on your modules, you'll be assessed through a combination of:

We offer a wide range of projects for the thesis. These will be provided by our academics. You can also propose your own topic.

Our mission is to help you:

  • stay healthy, positive and feeling well
  • overcome any challenges you may face during your degree – academic or personal
  • get the most out of your postgraduate research experience
  • carry out admin and activities essential to progressing through your degree
  • understand postgraduate research processes, standards and rules

We can offer you tailored wellbeing support, courses and activities.

You can also access a broad range of workshops covering:

  • research and professional skills
  • careers support
  • health and safety
  • public engagement
  • academic development

Find out more about our postgraduate research student support

Your development

Faculty of medical sciences (fms) researcher development programme .

Each faculty offers a researcher development programme for its postgraduate research students. We have designed your programme to help you:

  • perform better as a researcher
  • boost your career prospects
  • broaden your impact
  • Through workshops and activities, it will build your transferable skills and increase your confidence.

You’ll cover:

  • techniques for effective research
  • methods for better collaborative working
  • essential professional standards and requirements
  • Your programme is flexible. You can adapt it to meet your changing needs as you progress through your doctorate.

Find out more about the FMS researcher development programme

Doctoral training and partnerships

There are opportunities to undertake your PhD at Newcastle within a:

  • Centre for Doctoral Training (CDT)
  • Doctoral Training Partnership (DTP)

Being part of a CDT or DTP has many benefits:

  • they combine research expertise and training of a number of leading universities, academic schools and academics.
  • you’ll study alongside a cohort of other PhD students
  • they’re often interdisciplinary
  • your PhD may be funded

Find out more about doctoral training and partnerships

If there are currently opportunities available in your subject area you’ll find them when you search for funding in the fees and funding section on this course.

The following centres/partnerships below may have PhD opportunities available in your subject area in the future:

  • Discovery Medicine North - MRC DiMeN Doctoral Training Partnership
  • EPSRC Centre for Doctoral Training in Molecular Sciences for Medicine (MoSMed)
  • Newcastle Liverpool Durham BBSRC Doctoral Training Partnership

Your future

Our careers service.

Our award-winning Careers Service is one of the largest and best in the country, and we have strong links with employers. We provide an extensive range of opportunities to all students through our ncl+ initiative.

Visit our Careers Service website

Quality and ranking

All professional accreditations are reviewed regularly by their professional body

From 1 January 2021 there is an update to the way professional qualifications are recognised by countries outside of the UK

Check the government’s website for more information .

Our staff and postgraduate students work in:

  • the Northern Institute for Cancer Research (NICR)
  • the School of Natural and Environmental Sciences (medicinal chemistry students).

Our laboratories contain a full range of contemporary equipment used in:

  • synthetic chemistry
  • pharmacology
  • clinical research facilities

You'll work in the Faculty of Medical Sciences . This is part of our city-centre campus.

The Faculty is also home to:

It is on the same site as Newcastle’s Royal Victoria Infirmary hospital. We are one of the largest integrated teaching/hospital complexes in the country.

Our facilities include:

  • individual research laboratories where students carry out their projects
  • a dedicated medical library with a wide range of specialist books and journals
  • hi-tech computer clusters and study spaces
  • dedicated facilities for a range of key bioscience applications. This includes flow cytometry, bioinformatics, imaging, genomics and proteomics

Fees and funding

Tuition fees for 2024 entry (per year).

We are unable to give an exact fee, this is why the fee is shown as a range. This fee range takes into account your research topic and resource requirements.

Your research topic is unique so it will have unique resource requirements. Resources could include specialist equipment, such as laboratory/workshop access, or technical staff.

If your research involves accessing specialist resources then you're likely to pay a higher fee. You'll discuss the exact nature of your research project with your supervisor(s). You'll find out the fee in your offer letter.

Home fees for research degree students

For 2024-25 entry, we will be aligning our standard Home research fees with those set by UK Research and Innovation (UKRI) . The standard fee will be confirmed in Spring 2024 by UKRI. The Home tuition fees for this course will be updated after this confirmation. 

If your studies last longer than one year, your tuition fee may increase in line with inflation.

Depending on your residency history, if you’re a student from the EU, other EEA or a Swiss national, with settled or pre-settled status under the EU Settlement Scheme, you’ll normally pay the ‘Home’ tuition fee rate and may be eligible for Student Finance England support.

EU students without settled or pre-settled status will normally be charged fees at the ‘International’ rate and will not be eligible for Student Finance England support.

If you are unsure of your fee status, check out the latest guidance here .

Scholarships

We support our EU and international students by providing a generous range of Vice-Chancellor's automatic and merit-based scholarships. See  our   searchable postgraduate funding page  for more information.  

What you're paying for

Tuition fees include the costs of:

  • matriculation
  • registration
  • tuition (or supervision)
  • library access
  • examination
  • re-examination

Find out more about:

  • living costs
  • tuition fees

If you are an international student or a student from the EU, EEA or Switzerland and you need a visa to study in the UK, you may have to pay a deposit.

You can check this in the How to apply section .

If you're applying for funding, always check the funding application deadline. This deadline may be earlier than the application deadline for your course.

For some funding schemes, you need to have received an offer of a place on a course before you can apply for the funding.

Search for funding

Find funding available for your course

Entry requirements

The entrance requirements below apply to 2024 entry.

Qualifications from outside the UK

English language requirements, admissions policy.

This policy applies to all undergraduate and postgraduate admissions at Newcastle University. It is intended to provide information about our admissions policies and procedures to applicants and potential applicants, to their advisors and family members, and to staff of the University.

Download our admissions policy (PDF: 201KB) Other policies related to admissions

Credit transfer and Recognition of Prior Learning

Recognition of Prior Learning (RPL) can allow you to convert existing relevant university-level knowledge, skills and experience into credits towards a qualification. Find out more about the RPL policy which may apply to this course

  • How to apply

Using the application portal

The application portal has instructions to guide you through your application. It will tell you what documents you need and how to upload them.

You can choose to start your application, save your details and come back to complete it later.

If you’re ready, you can select Apply Online and you’ll be taken directly to the application portal.

Alternatively you can find out more about applying on our applications and offers pages .

Open days and events

You'll have a number of opportunities to meet us throughout the year including:

  • campus tours
  • on-campus open days
  • virtual open days

Find out about how you can visit Newcastle in person and virtually

Overseas events

We regularly travel overseas to meet with students interested in studying at Newcastle University.

Visit our events calendar for the latest events

  • Get in touch

Questions about this course?

If you have specific questions about this course you can contact:

Postgraduate secretary Centre for Cancer Telephone: +44 (0) 191 246 4300

For more general enquiries you could also complete our online enquiry form.

Fill in our enquiry form

Our Ncl chatbot might be able to give you an answer straight away. If not, it’ll direct you to someone who can help.

You'll find our Ncl chatbot in the bottom right of this page.

Keep updated

We regularly send email updates and extra information about the University.

Receive regular updates by email

Chat to a student

Chat online with current students with our Unibuddy platform.

Social media

Get involved with the School of Medical Sciences   social media

  • How You'll Learn
  • Your Development
  • Your Future
  • Quality and Ranking
  • Fees and Funding
  • Entry Requirements
  • Open days & events
  • Postgraduate Research

Cancer Biology PhD / MPhil / MD

  • Part time available: yes

Studying in:

  • institute-of-systems-molecular-and-integrative-biology
  • Faculty of Health and Life Sciences

A broad range of research interests provides for world-class research in cancer biology, supported by world-class clinical research into several major types of cancer.

Why study with us?

I've had the privilege of showcasing my work in several national and international meetings, and would highly recommend the university for any aspiring students. Mateus Milani - Cancer Biology PhD student

academic members of staff.

registered postgraduate research students.

Fundamental cancer research is aimed at providing the discoveries that can lead to new avenues of research that can ultimately be translated into patient benefits.

Scientific laboratory research work in the department is performed in an environment that has a wealth of clinical expertise and research which ensures that basic scientific research is always performed with insights of relevance to patients provided by leading clinical teams and an awareness of detailed clinical issues.

Our research interests include:

  • Fundamental research into the mechanisms leading to cancer development and progression with the aim of understanding the processes that lead to cancer development and which constitute potential therapeutic targets
  • Clinical studies conducted with the intent to advance therapies to the clinic or develop principles for application of therapeutics to human disease (part of the remit of the Cancer Research UK Experimental Cancer Medicine Centre)
  • Investigations in humans and human materials which define the biology of disease and provide the scientific foundation for the development of new or improved therapies for human disease
  • Translational research taking advantage of new and on-going clinical trials in cancer often of novel and modifications of existing therapies and also to develop novel predictive and prognostic biomarkers.

Research themes

  • Fundamental studies of cancer cells and the molecular biology of cancer
  • Pancreatic cancer
  • Haemato-Oncology
  • Head and Neck cancer
  • Liver Cancer
  • Lung cancer
  • Ocular cancers
  • Colorectal cancer
  • Gastro-oesophageal cancer
  • Urological cancer (including Renal Cancer)
  • Breast cancer

PhD students can take taught modules - on either a formal basis with exams taken and a record of completion generated or less formally. Commonly, students use the opportunity to upskill in areas like bioinformatics and statistics, but modules on defined areas of biology are also available. A wide variety of further development opportunities are available from the  PGR Development Hub . 

The Institute of Translational Medicine research infrastructure is designed to give researchers access to world class facilities in the best possible environment.

Our facilities give us the ability to drive biomedical research from patient samples to the laboratory bench and vice versa from newly generated drug compounds into clinical trials. The departments of the Institute have the following facilities and resources:

  • Biomedical Imaging
  • Centre for Antimicrobial Pharmacodynamics
  • Centre for Drug Safety Science
  • Health Data Science Network
  • Centre for Preclinical Imaging
  • Clinical Trials Research Centre
  • Harris-Wellbeing Preterm Birth Research Centre
  • Liverpool Bio-Innovation Hub (LBIH) Biobank
  • Liverpool Cancer Trials Unit
  • MRC North West Hub for Trials Methodology Research
  • North West Cancer Research Centre – University of Liverpool
  • Pancreas Biomedical Research Unit
  • UK Experimental Arthritis Treatment Centre for Children
  • Wolfson Centre for Personalised Medicine.

Study options and fees

Entry requirements.

Applicants for postgraduate research study at Liverpool are normally expected to hold a UK first degree with a First Class or Upper Second Class degree classification, or a Second Class degree plus a Master’s degree. Equivalent international qualifications are also accepted, and their equivalence will be evaluated on the basis of the information provided by the National Academic Recognition and Information Centre (NARIC) as well as internal guidance based on our experience of a qualification’s suitability as a preparation for our programmes.

English language requirements

How to apply.

Research degree applications can be made online.  You'll also need to ensure that you have funding to cover all fees.

Applications are  open all year round .

More about applying for research degrees

Apply online

Before you apply, we recommend that you identify a supervisor and develop a research proposal

Find a supervisor

View staff list

Need help finding a supervisor? Contact us

Related studentships: self-funded and funded PhD projects

Find a scholarship.

We offer a range of scholarships to help you meet the costs of studying a research degree.

See scholarships

Find a course

  • A-Z of courses /
  • Studentship vacancies

Undergraduate enquiries

International enquiries

Postgraduate taught enquiries

Postgraduate research enquiries

Ask the University of Liverpool a question

  • Undergraduate
  • Postgraduate Taught
  • Online programmes
  • Welcome to Liverpool

Learn about...

  • Visits and Open Days
  • Accommodation
  • Student support
  • Careers and Employability
  • Continuing Education
  • Continuing Professional Development

Information for...

  • International students
  • Mature students and access courses
  • Parents and supporters
  • School and careers advisors

University of Cambridge

Study at Cambridge

About the university, research at cambridge.

  • Undergraduate courses
  • Events and open days
  • Fees and finance
  • Postgraduate courses
  • How to apply
  • Postgraduate events
  • Fees and funding
  • International students
  • Continuing education
  • Executive and professional education
  • Courses in education
  • How the University and Colleges work
  • Term dates and calendars
  • Visiting the University
  • Annual reports
  • Equality and diversity
  • A global university
  • Public engagement
  • Give to Cambridge
  • For Cambridge students
  • For our researchers
  • Business and enterprise
  • Colleges & departments
  • Email & phone search
  • Museums & collections
  • Course Directory

PhD in Oncology

Postgraduate Study

  • Why Cambridge overview
  • Chat with our students
  • Cambridge explained overview
  • The supervision system
  • Student life overview
  • In and around Cambridge
  • Leisure activities
  • Student unions
  • Music awards
  • Student support overview
  • Mental health and wellbeing
  • Disabled students
  • Accommodation
  • Language tuition
  • Skills training
  • Support for refugees
  • Courses overview
  • Department directory
  • Qualification types
  • Funded studentships
  • Part-time study
  • Research degrees
  • Visiting students
  • Finance overview
  • Fees overview
  • What is my fee status?
  • Part-time fees
  • Application fee
  • Living costs
  • Funding overview
  • Funding search
  • How to apply for funding
  • University funding overview
  • Research Councils (UKRI)
  • External funding and loans overview
  • Funding searches
  • External scholarships
  • Charities and the voluntary sector
  • Funding for disabled students
  • Widening participation in funding
  • Colleges overview
  • What is a College?
  • Choosing a College
  • Terms of Residence
  • Applying overview
  • Before you apply
  • Entry requirements
  • Application deadlines
  • How do I apply? overview
  • Application fee overview
  • Application fee waiver
  • Life Science courses
  • Terms and conditions
  • Continuing students
  • Disabled applicants
  • Supporting documents overview
  • Academic documents
  • Finance documents
  • Evidence of competence in English
  • Terms and Conditions
  • Applicant portal and self-service
  • After you apply overview
  • Confirmation of admission
  • Student registry
  • Previous criminal convictions
  • Deferring an application
  • Updating your personal details
  • Appeals and Complaints
  • Widening participation
  • Postgraduate admissions fraud
  • International overview
  • Immigration overview
  • ATAS overview
  • Applying for an ATAS certificate
  • Current Cambridge students
  • International qualifications
  • Competence in English overview
  • What tests are accepted?
  • International events
  • International student views overview
  • Akhila’s story
  • Alex’s story
  • Huijie’s story
  • Kelsey’s story
  • Nilesh’s story
  • Get in touch!
  • Events overview
  • Upcoming events
  • Postgraduate Open Days overview
  • Discover Cambridge: Master’s and PhD Study webinars
  • Virtual tour
  • Research Internships
  • How we use participant data
  • Postgraduate Newsletter

Primary tabs

  • Overview (active tab)
  • Requirements
  • How To Apply

The PhD course is a three to four years full-time, or five to seven years part-time research-based course.

Full-time PhD students are probationary in the first year and progression to the second year (and registration for the PhD) depends on a successful first-year assessment. The first-year probationary assessment involves the submission of a written progress report that covers the research work completed, a review of appropriate literature and a clear indication of how the PhD will develop in the second and third years (i.e. future work). The report is assessed by two assessors and an oral examination of the report will be undertaken. 

Part-time students are on probation for their first two years and should complete their registration assessment before they enter their third year. In addition, full-time and part-time students are also required to produce regular written progress reports.

At the end of their course, students produce a thesis of 60,000 words maximum, followed by an oral examination based on both their thesis and a broader knowledge of their chosen area of research. Students are provided with information which clearly sets out what is expected of them in order to obtain their degree.

Most research training is provided within the structure of the student’s research group and informal opportunities to develop research skills are available through mentoring by other members of staff and fellow students. All students are encouraged to attend scientific meetings, seminars and postgraduate courses relevant to their area of interest. They are also expected to participate in journal clubs and lab meetings and to take advantage of the numerous and varied opportunities including transferable skills training offered by the University. 

Each student is assigned a Principal Supervisor who oversees their research project and an adviser who provides additional support. Our Postgraduate Administrator acts as the first point of contact for any student with a query or difficulty that is not directly related to their scientific work. All student matters in the department are overseen by our Director of Postgraduate Education and the Cancer Biology Postgraduate Education Committee.

The PhD course provides:

  • a period of a sustained in-depth study of a specific topic;
  • an environment that encourages the student’s originality and creativity in their research;
  • skills to enable the student to critically examine the background literature relevant to their specific research area;
  • the opportunity to develop skills in making and testing hypotheses, in developing new theories, and in planning and conducting experiments;
  • the opportunity to expand the student’s knowledge of their research area, including its theoretical foundations and the specific techniques used to study it;
  • the opportunity to gain knowledge of the broader field of cancer research; and
  • an environment in which to develop skills in written work, oral presentation and publishing the results of their research in high-profile scientific journals, through constructive feedback of written work and oral presentations.

Learning Outcomes

At the end of their PhD course, students should:

  • have a thorough knowledge of the literature and a comprehensive understanding of scientific methods and techniques applicable to their own research;
  • be able to demonstrate originality in the application of knowledge, together with a practical understanding of how research and enquiry are used to create and interpret knowledge in their field;
  • have developed the ability to critically evaluate current research and research techniques and methodologies;
  • have self-direction and originality in tackling and solving problems;
  • be able to act autonomously in the planning and implementation of research; and
  • have gained oral presentation and scientific writing skills.

Continuation from MPhil to PhD is possible although it is not automatic. All cases are judged on their own merits based on a number of factors, including evidence of progress and research potential; a sound research proposal; the availability of a suitable supervisor and of resources required for the research; and acceptance by the Head of Department and the Degree Committee.

Those who wish to progress to a PhD after completing an MPhil by thesis will be required to obtain a pass.

The Postgraduate Virtual Open Day usually takes place at the end of October. It’s a great opportunity to ask questions to admissions staff and academics, explore the Colleges virtually, and to find out more about courses, the application process and funding opportunities. Visit the  Postgraduate Open Day  page for more details.

See further the  Postgraduate Admissions Events  pages for other events relating to Postgraduate study, including study fairs, visits and international events.

Key Information

3-4 years full-time, 4-7 years part-time, doctor of philosophy, department of oncology, course - related enquiries, application - related enquiries, course on department website, dates and deadlines:, lent 2024 (closed).

Some courses can close early. See the Deadlines page for guidance on when to apply.

Easter 2024 (Closed)

Michaelmas 2024, easter 2025, funding deadlines.

These deadlines apply to applications for courses starting in Michaelmas 2024, Lent 2025 and Easter 2025.

Similar Courses

  • Medical Science (Oncology) MPhil
  • Obstetrics and Gynaecology PhD
  • Biotechnology MPhil
  • Biological Sciences (Developmental Biology) by advanced study MPhil
  • Cancer Biology (part-time) PhD

Postgraduate Admissions Office

  • Admissions Statistics
  • Start an Application
  • Applicant Self-Service

At a glance

  • Bringing a family
  • Current Postgraduates
  • Cambridge Students' Union (SU)

University Policy and Guidelines

Privacy Policy

Information compliance

Equality and Diversity

Terms of Study

About this site

About our website

Privacy policy

© 2024 University of Cambridge

  • Contact the University
  • Accessibility
  • Freedom of information
  • Privacy policy and cookies
  • Statement on Modern Slavery
  • University A-Z
  • Undergraduate
  • Postgraduate
  • Research news
  • About research at Cambridge
  • Spotlight on...

Barts Cancer Institute

  • Barts Cancer Institute
  • Life as a Researcher
  • Centre of the Cell
  • Walking Tour
  • Patient and Public Involvement
  • Our Heritage
  • Research Centres
  • Our Research
  • Core Services
  • Centre for Experimental Cancer Medicine
  • Scientific Advisory Board
  • Staff Directory
  • Centre Leads
  • Group Leaders
  • Postdoctoral Researchers
  • Postgraduate Research
  • Postgraduate Teaching
  • Short Courses

Postgraduate Research at Barts Cancer Institute

At Barts Cancer Institute (BCI) we have over 100 research students, consisting of both scientists and clinicians, working on a wide range of projects across the Institute. We offer the following research programmes:

  • PhD (non-clinical)
  • PhD (clinical)

We offer a comprehensive support programme for our research students, providing training in a wide range of biomedical laboratory methods and other vital transferable skills. Our aim is to equip students for a career in science and to make them attractive to a variety of potential employers.

Funded Studentships

Each year we offer around 10-15 new PhD studentships funded from a variety of sources, including UK Research Councils and various charities. These are advertised throughout the year. Please visit our  Opportunities  section for current studentships.

We also have the following studentship programmes running each year:

Cancer Research UK Non-Clinical PhD studentships & Clinical Research Fellowships

  • This training programme, part of a multimillion pound award from Cancer Research UK (CRUK), aims to develop a cohort of scientists equipped both intellectually and technically to conduct the highest quality research in cancer.
  • Applicants will be able to select from a variety of projects offered by our research centres
  • This programme is usually advertised in September/October each year

MRC combined MRes and PhD Doctoral Training Partnership Programme in Translational Biomedical Sciences

  • Delivered in partnership with the University of Southampton
  • Students will complete an MRes in year 1 before progressing to a PhD
  • The MRes will involve 3 taught modules and 3 rotational projects.
  • Students will then select one of their MRes rotational projects as the subject of their PhD
  • Find out more and read about some student experiences

PhD Studentships & Fellowships Mailing List

Study with us mailing list signup.

  • Your Email *
  • Clinical Research Fellowships
  • Non-clinical studentships
  • I understand that Queen Mary University of London will store my submitted information and I consent to its use for communications in relation to available studentships and/or fellowships

If at any point you would like to be removed from this mailing list, please contact the BCI Teaching Centre stating that you would like to be removed from the list.

Speculative PhD/MD(Res)

If you have already secured your own funding and would like to register for a PhD with Barts Cancer Institute, please look at our  research areas  and contact some potential  supervisors  to discuss a suitable project.

If you are unsure, or require further academic assistance please contact  Dr Sarah-Anne Martin  (Director of Graduate Studies), who will be able to advise you further.

Once you have identified a suitable project and supervisor please submit an online application. You will be required to provide the following supporting documents:

  • Confirmation of funding for the duration of the PhD/MD(Res)
  • Research Proposal
  • Statement of Purpose (usually one side of A4)
  • Degree transcripts
  • 2 references (at least one of these must be an academic reference)
  • English Language certificate (if applicable)

You will need to secure funding for:

  • 3 years for a PhD (or part time equivalent
  • 2 years for an MD(Res) (or part time equivalent)

Funding will need to cover:

  • Tuition Fees
  • Project consumables (to be agreed by the supervisor)
  • Living costs (approximately £15,000 per annum)

For any general enquiries please contact the  BCI Teaching Office .

Entry Requirements

Advertised studentships will include details of any specific entry requirements. General entry requirements for our research programmes are given below.

All applicants should have or be expecting:

  • A first or upper second class honours degree in a relevant biological subject from a UK university or the international equivalent from a recognised institution. For international equivalencies please see  Queen Mary International Office . Or;
  • A medical degree from a recognised institution

Clinical Research Fellows

All applicants must have:

  • Full GMC registration
  • Clinical experience relevant to the post
  • Research experience relevant to the project
  • A national training number or to be eligible for one

English Language Requirements

Applicants for whom English is not a first language will also require a minimum IELTS score of 6.5 (with 6.0 in writing) or equivalent, unless their undergraduate degree was studied in, and awarded by, an  English-speaking country . For more information on acceptable English language qualifications please visit the Queen Mary website .

Programme Structure

PhD - Full Time 3 years research + maximum 1 year for writing up

PhD - Part Time 6 years research + maximum 1 year for writing up

MD(Res) - Full Time 2 years research + maximum 1 year for writing up

MD(Res) - Part Time 4 years research + maximum 1 year for writing up

Enrolment and Induction

If your application is successful you will receive an official offer from the Admissions Team.

  • Enrolment takes place on the first working day of each month at the Mile End campus. You will receive an e-mail detailing what is required to complete this process
  • You will have a brief induction with the BCI Teaching Office, your supervisor and the Centre Administrator of the research lab you are joining.
  • The main induction takes place over 2 days at the beginning of the autumn and spring semester and counts towards your annual transferable skills.
  • For any questions contact the Teaching Office:  [email protected]

Student Life

At Barts Cancer Institute, you will find a rich social life, something which  past and current students have noted as one of the highlights of the Institute. Within the laboratory, there is a strong sense of community, with the emphasis on group-driven research work creating a highly collaborative and sociable environment.

There is a dedicated social committee which helps to organise sporting events, pub quizzes and excursions throughout the year, helping you to make the most of this fascinating city in the company of fellow scientists from across the Institute.

It is difficult to imagine a more vibrant and exciting place to be a student than London. The  Charterhouse Square campus is ideally placed for exploring the city, with underground and bus routes located nearby to roam further afield.

Barts and The London School of Medicine and Dentistry

Barts Cancer Institute was formed in 2003 and is 1 of 7 Institutes within  Barts and The London School of Medicine and Dentistry . Barts and The London School of Medicine and Dentistry is part of Queen Mary University of London .

Barts and The London School of Medicine and Dentistry brings together two venerable teaching institutions: St Bartholomew's Hospital, which dates back to 1123, and The London Hospital Medical College, which was the first medical school in England and Wales, founded in 1785.

Today Barts and The London School of Medicine and Dentistry is ranked 1st in London for Medicine ( The Complete University Guide 2021 - subject rankings ). 

Postgraduate Research Opportunities

Are you an international student, our campus and facilities.

phd cancer uk

Lavanya, PhD Student

"I love living and working in London and this was a big part of my decision to pursue my postgraduate studies here. The collaborative atmosphere at BCI is great and it’s nice to know there will always be someone around to help with troubleshooting a problem in the lab or during data analysis. The range of different research projects undertaken here also promotes a great environment for collaborations between departments. This provides regular opportunities to attend talks and seminars on a diverse range of research topics. As a PhD student, it is refreshing to be able to hear about recent developments in areas of research that are outside of your specific project."

Read Lavanya's full Life as a Researcher profile

phd cancer uk

Sheila, PhD Student

"During my time at BCI, I have worked closely with varied supervisors across diverse departments and universities. This has given me a comprehensive understanding of the wider work being carried out in the cancer ecosystem and has enabled me to navigate my PhD project holistically. This has also been key in establishing a strong scientific network and forging new and potentially life-long friendships."

Read Sheila's full Life as a Researcher profile

Get in touch

Connect with us.

Follow our social media pages for the latest news and updates

Relevant links

Fee information, accomodation, international office, msc funding opportunities.

University of Cambridge

Study at Cambridge

About the university, research at cambridge.

  • Events and open days
  • Fees and finance
  • Student blogs and videos
  • Why Cambridge
  • Qualifications directory

How to apply

  • Fees and funding
  • Frequently asked questions
  • International students
  • Continuing education
  • Executive and professional education
  • Courses in education
  • How the University and Colleges work
  • Visiting the University
  • Term dates and calendars
  • Video and audio
  • Find an expert
  • Publications
  • International Cambridge
  • Public engagement
  • Giving to Cambridge
  • For current students
  • For business
  • Colleges & departments
  • Libraries & facilities
  • Museums & collections
  • Email & phone search
  • Cancer Research UK Cambridge Institute
  • Transparency in research
  • Support our research
  • Virtual tour
  • Research involving animals
  • Equality, Diversity and Inclusion
  • Response to COVID-19
  • Getting here
  • Research Groups
  • Core Facilities
  • Life at the Institute
  • Career development
  • College membership
  • Support and supervision
  • Student community
  • Student Testimonials
  • Undergraduate Summer Research Programme
  • Work experience and internships
  • Cambridge Makerere Summer School
  • Cambridge Festival
  • Institute news
  • CRUK Science Blog
  • Our Progress

PhD students at the CRUK Cambridge Institute

The Institute is committed to training the scientific leaders of tomorrow. Our MPhil and PhD programmes prepare students for fulfilling careers in academia, industry, or roles outside of the lab.

Phd in medical science.

The PhD in Medical Science course at the CRUK CI allows students to become fully embedded within their Principal Supervisor’s research team, giving them close interactions with postgraduate and postdoctoral colleagues. Each student will focus on a specific project aligned with the research group, enabling them to contribute to the overall objectives of both the lab and the Institute.

We expect our students to take ownership of their project, driving it forward with assistance from other members of the Institute, which encourages each student to develop the skills they need to become a successful independent researcher. Within four years of commencing study, students are supported to submit their thesis and to prepare their research findings for publication in scientific journals.

Approximately half our PhD students receive funding from Cancer Research UK. In addition, funding may be available from grants held by individual research groups. We also host Clinical Research Training Fellows and students on the Cambridge MB/PhD programme. We welcome applications from students who have won competitive studentships or fellowships.

Prospective students can apply in response to an advertisement placed by the Institute (please follow application instructions n the advertisement). Or if you intend to apply for independent funding (or have already done so) please contact your preferred supervisor before completing an online application via the University of Cambridge Applicant Portal . Please note that you are allowed to apply for both Institute funding and also an alternative independent source of funding for your studies.

All advertised projects include full funding for University and College fees and a stipend of £21,000 per annum. Applications for our PhD Programme are now open – please check our Vacancies page for individual projects.

MPhil in Medical Science

The MPhil in Medical Science research course at the CRUK CI integrates each student within the research team of their supervisor. Working alongside other postgraduate and postdoctoral colleagues, our MPhil students focus on their own projects which are expected to contribute to the advancement of the research of their group. MPhil students are encouraged to attend scientific talks of interest and appropriate training courses that support their study, as well as to participate in all aspects of postgraduate student life at the Institute. At the end of the study period, MPhil students are supported to write a thesis detailing their project. The Institute accepts only a few MPhil students each year, and in the main, applicants are successful if they are recognised as bringing a valuable technique or methodology to their research group.

The Institute provides a single studentship annually, so we recommend prospective students explore alternative funding options before applying.

Prior to submitting the University’s online application form, you should identify a supervisor in the Institute who is willing to host you for MPhil study.

More details about the application process, fees, and other entry requirements can be found on the  postgraduate admissions website . The University and the CRUK Cambridge Institute value diversity and are committed to  equality of opportunity .

CRUK CI staff links

Contact cruk ci, useful links.

  • Privacy statement
  • Terms and conditions

Connect with us

© 2024 University of Cambridge

  • University A-Z
  • Contact the University
  • Accessibility
  • Freedom of information
  • Undergraduate
  • Spotlight on...
  • About research at Cambridge

This Site Uses Cookies

We may use cookies to record some preference settings and to analyse how you use our web site. We may also use external analysis systems which may set additional cookies to perform their analysis.These cookies (and any others in use) are detailed in our site privacy and cookie policies and are integral to our web site. You can delete or disable these cookies in your web browser if you wish but then our site may not work correctly.

The University of Manchester home

Train as a clinician-scientist

Cancer Research UK MB-PhD

Why choose this programme, combine medical training with research.

The Cancer Research UK MB-PhD is a fully funded three-year programme aimed at MBChB students wishing to intercalate to train as clinician scientists.

This training route will see you work towards both your MBChB and PhD awards over the course of the programme, combining your medical training with research training in the area of cancer sciences.

Each year, we aim to recruit the best candidates who are seeking to drive new innovations in clinical care and research. Our first cohort of students started their studies in September 2020.

Why cancer sciences?

Cancer sciences is such a broad area that it can be applicable in all aspects of medicine, surgery and general practice.

You will develop invaluable transferable skills and be fully equipped to start a career in clinical research.

Cancer sciences is linked to areas of medicine such as:

  • clinical oncology
  • clinical genetics
  • medical oncology

On this page:

Eligibility criteria

Making an application.

  • Undergraduate summer placements

More about the MB-PhD

What is a clinician scientist.

Clinician scientists play an essential role in cancer research, bridging the gap between patients and scientific research.

Working across both the clinic and the laboratory, clinician scientists are in a unique position to reflect the needs of people with cancer in the discovery of new treatments and tests.

Learn more about clinical academic training and careers

What is a PhD?

A PhD is one of the highest-level academic degrees that can be awarded.

Unlike most undergraduate and master’s programmes, a PhD is a pure research degree but this doesn’t mean that you will only spend three years in a library or lab.

There are many opportunities for professional development including; networking and communication, teaching, presenting at conferences and opportunities to publish work.

Why should I do a PhD during my MBChB?

Currently, most UK trainee clinician scientists take on a PhD after completing their initial medical training, often when they are in their thirties.

Cancer Research UK launched their nationwide MB-PhD programme after seeing a decline in the number of clinicians on an academic career pathway, particularly female researchers.

Doing a PhD during medical school can accelerate your academic career before you get too embedded in clinical work or have other commitments.

The skills you will acquire can be applied in many areas of medicine and you will learn valuable critical appraisal skills early.

On completion of your MB-PhD you will graduate as a doctor at the forefront of your field.

A combined approach

You will benefit from a bespoke training and mentorship programme alongside your research project.

You will be part of the Manchester Cancer Research Centre and Cancer Research UK Manchester Centre , which host regular seminars and lectures with speakers; from postgraduate trainees up to world-leading international researchers. They also host career development events.

As a postgraduate researcher in the Faculty of Biology, Medicine and Health, you will also have access to the Doctoral Academy Training programme to develop your transferable skills.

Learn more about our current CRUK MB-PhD students:

  • Hadiyat Ogunlayi
  • Nadin Hawwash

Programme structure

  • Programme induction
  • Project specific training/development
  • Upskilling in cancer sciences
  • Completion of literature and continuation review

Researchers analysing a sample in the lab.

  • Training activities to support career development
  • Social responsibility
  • Second year progress report

A group of medical students reading text books.

  • Thesis planning and submission
  • Viva examination
  • Support for returning to the MBChB core programme

A researcher using a tablet to record observations during an experiment.

  • Continued mentorship
  • Continued research engagement and opportunities via your supervisory group

A postgraduate student chatting with a mentor.

Helping you choose a project

The list of projects and their details are available on the CRUK Manchester website. Applications are open for the September 2024 intake. 

MB-PhD research projects

Discuss your project

Prospective candidates are strongly encouraged to contact multiple potential supervisors directly to discuss their advertised projects and research. For general queries and/or supervisor details, please contact us.

Dr Georgina Binnie-Wright  (Postgraduate Programme Manager) Email:  [email protected]

What the funding covers

Successful applicants will receive a PhD studentship for the three-year duration of the programme, which includes:

Fees and stipend

  • full funding for PhD tuition fees (up to the UK rate)
  • lab costs/running expenses
  • a stipend of £21,000 per annum for living costs

A researcher studying samples under a microscope.

International candidates

International candidates should contact the Postgraduate Programme Manager to discuss fee scholarships available to the highest-performing international applicants at interview.

Researchers analysing data on a lab computer.

Student loan eligibility

An undergraduate Student Loans Company payment up to a maximum of four years of MBChB study (including interest accrued to SLC if appropriate), subject to successful completion of key years of study.

Researchers at work in the lab.

Who can apply

Candidates should be MBChB students at The University of Manchester or BSc (Hons) Medicine students at the University of St Andrews.

The University of Manchester

University of Manchester MBChB students must be either:

  • currently studying in Year 3; or
  • currently studying in Year 2 and already holding a BA/BSc (Hons) degree classification of an Upper Second or above in a relevant subject;
  • or intercalating after either Year 2 or Year 3 of the MBChB.

University of St Andrews

University of St Andrews Medicine BSc (Hons) students on the Manchester course pathway must be:

  • currently studying on Year 3 of the Manchester MBChB, having already obtained a BSc classification of an Upper Second (2:1) or above from the University of St Andrews;
  • predicted to obtain a BSc classification of an Upper Second (2:1) or above from the University of St Andrews.

Apply for the programme

Each year, we recruit a number of undergraduate students onto our three-year PhD programme, with the approval of relevant intercalation teams. In some cases, projects may be four years in duration.

We are looking for candidates who are seeking to drive new innovations in clinical care and research.

If you wish to be considered for a studentship and meet our eligibility criteria, you must complete a single online application.

Full details on eligibility and residence criteria are available via the instructions below.

How to apply

  • Application deadline: Monday 12 February 2024
  • Applicants meet with MB-PhD programme director: Thursday 29 February 2024
  • Interviews: Monday 11 March 2024
  • Start date: September 2024

Under­graduate summer placements

Try out a research project.

Each year, we offer research opportunities within the MB-PhD to University of Manchester and St Andrews-Manchester Pathway Medical School students.

Placements for summer 2024 will be advertised in due course.

Medical student looking down a microscope.

Have any questions? Get in touch.

Queries regarding the application process and funding can be sent to Dr Georgina Binnie-Wright, MCRC-CRUK Manchester Centre Postgraduate Programme Manager.

Email: [email protected]

University of Manchester intercalation queries should be sent to Professor Sue Atley and the intercalation team.

Email: [email protected] / [email protected]

Together we are beating cancer

About cancer

Cancer types

  • Breast cancer
  • Bowel cancer
  • Lung cancer
  • Prostate cancer

Cancers in general

  • Clinical trials

Causes of cancer

Coping with cancer

  • Managing symptoms and side effects
  • Mental health and cancer
  • Money and travel
  • Death and dying
  • Cancer Chat forum

Health Professionals

  • Cancer Statistics
  • Cancer Screening
  • Learning and Support
  • NICE suspected cancer referral guidelines

Get involved

  • Make a donation

By cancer type

  • Leave a legacy gift
  • Donate in Memory

Find an event

  • Race for Life
  • Charity runs
  • Charity walks
  • Search events
  • Relay For Life
  • Volunteer in our shops
  • Help at an event
  • Help us raise money
  • Campaign for us

Do your own fundraising

  • Fundraising ideas
  • Get a fundraising pack
  • Return fundraising money
  • Fundraise by cancer type
  • Set up a Cancer Research UK Giving Page
  • Find a shop or superstore
  • Become a partner
  • Cancer Research UK for Children & Young People
  • Our We Are campaign

Our research

  • Brain tumours
  • Skin cancer
  • All cancer types

By cancer topic

  • New treatments
  • Cancer biology
  • Cancer drugs
  • All cancer subjects
  • All locations

By Researcher

  • Professor Duncan Baird
  • Professor Fran Balkwill
  • Professor Andrew Biankin
  • See all researchers
  • Our achievements timeline
  • Our research strategy
  • Involving animals in research

Funding for researchers

Research opportunities

  • For discovery researchers
  • For clinical researchers
  • For population researchers
  • In drug discovery & development
  • In early detection & diagnosis
  • For students & postdocs

Our funding schemes

  • Career Development Fellowship
  • Discovery Programme Awards
  • Clinical Trial Award
  • Biology to Prevention Award
  • View all schemes and deadlines

Applying for funding

  • Start your application online
  • How to make a successful application
  • Funding committees
  • Successful applicant case studies

How we deliver research

  • Our research infrastructure
  • Events and conferences
  • Our research partnerships
  • Facts & figures about our funding
  • Develop your research career
  • Recently funded awards
  • Manage your research grant
  • Notify us of new publications

Find a shop

  • Volunteer in a shop
  • Donate goods to a shop
  • Our superstores

Shop online

  • Wedding favours
  • Cancer Care
  • Flower Shop

Our eBay store

  • Shoes and boots
  • Bags and purses
  • We beat cancer
  • We fundraise
  • We develop policy
  • Our global role

Our organisation

  • Our strategy
  • Our Trustees
  • CEO and Executive Board
  • How we spend your money
  • Early careers

Cancer news

  • Cancer News
  • For Researchers
  • For Supporters
  • Press office
  • Publications
  • Update your contact preferences

ABOUT CANCER

GET INVOLVED

NEWS & RESOURCES

FUNDING & RESEARCH

You are here

phd cancer uk

Black Leaders in Cancer PhD Scholarship Programme

About this scheme, how to apply to this scheme, key information.

Our programme is aimed at students from Black heritage backgrounds pursuing a PhD in cancer-related fields. 

This scheme is open to people who self-identify as being from a Black heritage background, including a mixed background, for example: Black African, Black Caribbean, Black Other, Mixed background (to include Black African, Black Caribbean or other Black backgrounds). 

You must also meet the general entry requirements for the PhD programme at a Cancer Research UK Centre, which typically include: 

hold or expect to graduate with a first or upper-second class undergraduate honours degree or equivalent in a relevant subject (or equivalent from a non-UK university) 

have appropriate research experience as part of, or outside of, an undergraduate or masters degree course in a relevant subject 

meet English language requirements as set by host institution 

Please read our frequently asked questions for more information on eligibility.

About the programme  

As part of our commitment to  Equality, Diversity and Inclusion in Research , we have developed this programme in  consultation with our research community  and in close collaboration with our expert partners, Black in Cancer and the  Windsor Fellowship . 

We plan to grow the programme over time and will review it to consider expanding eligibility to other groups which are also underrepresented in our research community.  

Read our interview with the programme leads to find out how programmes like this can help create a more diverse and inclusive research community.

You will be provided with:  

a fully-funded 4-year PhD studentship (non-clinical) according to our standard  PhD funding rates  including stipend, research consumables and UK home tuition fees 

a place on one of the doctoral training programmes at one of our Centres

a comprehensive programme of mentoring, career support, leadership training and networking led by the Windsor Fellowship and Black in Cancer, in addition to the support provided by our Centres, to drive your career forward and realise your full potential to beat cancer

Four studentship places are available for our second round starting in September 2024. Two of these will be at our City of London Centre and two at our Cambridge Centre.

Before applying, please read our eligibility criteria and frequently asked questions . We also recommend attending one of our informational insight sessions .

To apply, we ask you to: 

Submit a formal application to the Windsor Fellowship  (opens from October 2023)

  • Apply for your PhD studentship by submitting a PhD application to either our City of London Centre or our Cambridge Centre  (both applications opening from October 2023)

If you're shortlisted, you'll be invited to attend an interview at one of these Centres. 

Timeline summary

  • 21 September: insight session
  • 11 October: insight session 
  • from October  applications via Windsor Fellowship and the Centres 
  • 9 November: City of London Centre applications close
  • 15 November:  Cambridge Centre applications close 
  • January 2024: Centre interviews
  • September 2024: PhD starts for successful applicants 

If you have any questions about the Black Leaders in Cancer PhD scholarship programme, please get in touch with: 

Dr Silvia Panico 

[email protected]  

Fostering Black leadership in cancer research

We caught up with Abena Amponsah, one of our first Black Leaders in Cancer PhD students, to talk about the beginning of her academic journey.

  • International edition
  • Australia edition
  • Europe edition

A consultant analysing a mammogram

Surge in UK cancer patients going private revealed as King Charles starts treatment

Exclusive: As NHS targets are being missed nearly 300,000 people paid for chemotherapy in last five years

Hundreds of thousands of cancer patients in the UK are being forced to pay for private treatment amid record NHS waiting times, according to data obtained by the Guardian.

The figures emerged as King Charles began treatment for the disease within days of being diagnosed. Buckingham Palace has not specified whether the king is receiving private healthcare or being treated on the National Health Service.

While the king is already receiving expert care, his treatment will draw fresh attention to the long cancer waiting times in the state-run NHS, which is widely regarded by experts as being in crisis.

The proportion of patients in England waiting less than 62 days from an urgent suspected cancer referral or consultant upgrade to their first definitive treatment for cancer is 65.2%, according to the most recent figures. The target is 85%.

The figures, for November, show that one in 10 people are being denied treatment within 31 days of their cancer being found and a decision being made to treat them. Some 90.1% are seen within this timeframe in England, lower than the 96% NHS target.

Amid growing frustration at NHS waiting lists, record numbers of people are paying for private healthcare. Nearly 300,000 people in the UK have paid for chemotherapy in the last five years, figures provided to the Guardian show.

Between 2018 and 2023, 282,560 people funded chemotherapy treatments through insurance, according to the Private Healthcare Information Network, an independent, government-backed information service about private consultants and hospitals. A further 13,900 paid for their own chemotherapy, the data shows.

The PHIN said it could not provide figures for people paying to undergo cancer surgery, radiotherapy or other forms of private cancer treatment. It means the total number of people paying for private cancer treatment is likely to be even higher.

On Monday, the king spent the night at his Clarence House home near Buckingham Palace after beginning a series of outpatient treatments within days of his diagnosis.

The cancer was discovered when Charles stayed three nights last month in the London Clinic, an exclusive private hospital in Marylebone, where he underwent a corrective procedure for a benign enlarged prostate.

Buckingham Palace has not specified which healthcare provider is treating the king. But it is understood that in selecting providers, a balance of factors was taken into account. They included his privacy and security, the most appropriate specialists for the condition, and the potential impact on other patients and on the resources of the NHS and other healthcare providers.

after newsletter promotion

Amid record waiting times for cancer treatment on the NHS, survival rates for cancer in the UK lag behind those of other European countries for nine out of 10 of the most common types of the disease, according to an NHS Confederation report published in January.

A separate report commissioned by Cancer Research UK last week said progress in UK cancer survival was now slower than it has been for 50 years. The study said the UK lagged behind comparable countries, such as Australia, Canada, Denmark and Norway, in tackling the disease.

Researchers said cancer waiting times across the country were among the worst on record, too many cancers were diagnosed at a late stage, and access to treatment was unequal.

The NHS in England said on Tuesday that it was seeing and treating record numbers of people for cancer, with 30% more people treated last year than in 2015-16 and almost 3 million people receiving potentially life-saving cancer checks in the last 12 months.

“It is vital that people come forward if they are concerned about cancer symptoms – getting checked early saves lives,” a spokesperson added.

The alternative manifesto: Securing the future of the NHS

On Tuesday 27 February, 8pm-9.15pm GMT, join Denis Campbell, Narda Ahmed, Siva Anandaciva and Greg Fell as they discuss what an alternative manifesto for health and social care could look like. Book tickets here or at theguardian.live

  • King Charles III

More on this story

phd cancer uk

More than a third of cancer patients in England face potentially deadly delays

phd cancer uk

Oesophageal cancer test ‘should be made more available in UK’

phd cancer uk

Indian model Poonam Pandey fakes death to raise cervical cancer awareness

phd cancer uk

Global cancer cases to rise by more than 75% by 2050, WHO predicts

phd cancer uk

People in England with Jewish ancestry to be offered test to detect cancer risk

phd cancer uk

NHS data for England showing rise in cancer checks is misleading, say experts

phd cancer uk

Two in five adults in England would not ask GP about possible cancer symptoms

phd cancer uk

UK cancer care in crisis and patients will die due to lack of strategy, experts warn

phd cancer uk

AI better than biopsy at assessing some cancers, study finds

phd cancer uk

Rise in mouth cancer deaths linked to NHS dentist shortages, say campaigners

Most viewed.

Procedure for an enlarged prostate led to King Charles’ cancer diagnosis

King Charles III was diagnosed with cancer after he underwent a procedure for an enlarged prostate, Buckingham Palace said Monday, but it did not say what kind of cancer it was or how serious the condition is.

“During The King’s recent hospital procedure for benign prostate enlargement, a separate issue of concern was noted. Subsequent diagnostic tests have identified a form of cancer,” the palace said in a statement.

It is unclear what form of cancer was detected, but the palace said Charles does not have prostate cancer. 

An enlarged prostate is not linked to cancer, and it is relatively common among older men: Around 80% of men over age 70 have it, according to Yale Medicine. Charles turned 75 in November.

Sometimes, the condition can lead to symptoms such as difficulty urinating, loss of bladder control or waking up at night to urinate multiple times. In such cases, doctors will often recommend a transurethral resection, a procedure to remove extra prostate tissue.

“They go in and they scrape some tissue so that you can pee better, because the problem with the prostate is it’s sitting right at the base of the bladder and it can block urination,” said Dr. William Oh, the chief medical officer of the Prostate Cancer Foundation.

Part of a transurethral resection involves inserting a scope — a tube with a camera at the end — through the urethra. That way, doctors can see the prostate and know where to remove the tissue.

The scope could detect cancer in nearby areas, such as the bladder or the urethra, said Dr. Christian Pavlovich, a professor of urology and oncology at Johns Hopkins School of Medicine. 

“Sometimes you’ll have a bladder tumor or something that’s not symptomatic, and you’ll just see it when you go in there,” he said. 

A scope could also detect bloody urine, "which could signify something bleeding from the kidney," said Dr. Justin Friedlander, a professor of urologic oncology at Fox Chase Cancer Center. That could be a sign of kidney cancer or cancer in the ureter, he said — the tube that passes urine from the kidney to the bladder.

In other instances, doctors may find cancerous tissue that originated in other parts of the body when they’re analyzing prostate tissue that was removed during surgery.

“The prostate could be affected by cancers that are not really of prosthetic origin, like a lymphoma — one of those blood tumors — or a cancer of the urothelium, which is the lining of the urethra and bladder,” Pavlovich said. 

That would signal the cancer had spread from other organs and was potentially more advanced, Friedlander said.

Dr. Julio Pow-Sang, the chair of the genitourinary oncology program at Moffitt Cancer Center in Tampa, Florida, said it’s generally rare to find cancerous tissue during a procedure for prostate enlargement.

He said that “90 or 95% of the times it’s benign, but you could have a surprise.”

Buckingham Palace did not specify Monday what kind of procedure Charles underwent for an enlarged prostate, but it has previously referred to it as “corrective.”

Sometimes, instead of performing a transurethral resection, doctors will destroy excess prostate tissue with a laser or high heat — but those procedures are less common.

According to Buckingham Palace, Charles arrived in London on Monday to begin regular outpatient treatments for cancer.

“His Majesty is grateful to his medical team for their expert care and swift intervention, is wholly positive about his treatment and looks forward to returning to full public duty as soon as possible,” the palace said.

phd cancer uk

Aria Bendix is the breaking health reporter for NBC News Digital.

  • Work & Careers
  • Life & Arts

Become an FT subscriber

To read this article for free Register now

Once registered, you can:

  • Read free articles and add your comments
  • Get our Editor's Digest newsletter and more
  • Follow topics and set up personalised events
  • Access Alphaville: our markets and finance blog
  • Global news & analysis
  • Expert opinion
  • Special features
  • FirstFT newsletter
  • Videos & Podcasts
  • Android & iOS app
  • FT Edit app
  • 10 gift articles per month

Explore more offers.

Standard digital.

  • FT Digital Edition

Premium Digital

Print + premium digital.

Then $75 per month. Complete digital access to quality FT journalism. Cancel anytime during your trial.

  • 10 additional gift articles per month
  • Global news & analysis
  • Exclusive FT analysis
  • Videos & Podcasts
  • FT App on Android & iOS
  • Everything in Standard Digital
  • Premium newsletters
  • Weekday Print Edition

Then $29 per 3 months. The new FT Digital Edition: today’s FT, cover to cover on any device. This subscription does not include access to ft.com or the FT App.

  • Everything in Print
  • Everything in Premium Digital

Essential digital access to quality FT journalism on any device. Pay a year upfront and save 20%.

Terms & Conditions apply

Explore our full range of subscriptions.

Why the ft.

See why over a million readers pay to read the Financial Times.

International Edition

Watch CBS News

King Charles III's cancer was "caught early," U.K. Prime Minister Rishi Sunak says

By Tucker Reals

Updated on: February 9, 2024 / 10:19 AM EST / CBS News

Doctors have detected cancer in Britain's King Charles III, Buckingham Palace said in a statement Monday. The unspecified cancer was discovered as doctors treated the monarch for an enlarged prostate just over a week ago.

  • Camilla says King Charles "doing extremely well" after cancer diagnosis, but what is her role?

British Prime Minister Rishi Sunak told CBS News partner network BBC News Tuesday that Charles' cancer was "caught early."

Sunak said, "Like everyone else, we're shocked and sad, and just all our thoughts are with him and his family. Thankfully, this has been caught early and now everyone will be wishing him, that he gets the treatment that he needs and makes a full recovery. That's what we're all hoping and praying for."

What type of cancer does King Charles III have?

It is understood that the king has been diagnosed with cancer elsewhere in his body, not of the prostate.

The king, 75, was discharged one week ago following treatment for an enlarged prostate, which the palace said was not cancerous. During that treatment, however, a "separate issue of concern was noted. Subsequent diagnostic tests have identified a form of cancer."

King Charles III through the years

Buckingham Palace said Charles had "commenced a schedule of regular treatments," and that during that treatment he would "postpone public-facing duties." It said he would continue with his official business and office work as usual.

"The King is grateful to his medical team for their swift intervention, which was made possible thanks to his recent hospital procedure. He remains wholly positive about his treatment and looks forward to returning to full public duty as soon as possible," the statement said, adding that the monarch had "chosen to share his diagnosis to prevent speculation and in the hope it may assist public understanding for all those around the world who are affected by cancer."

How long has Charles been king?

Charles has been king for less than a year and a half after inheriting the monarchy upon the death of his mother, Queen Elizabeth II , in September 2022. He was crowned several months later, on May 6, 2023. His health was generally understood to have been good. He had a noncancerous growth removed from his face in 2008, according to The Associated Press.

Charles was admitted a couple weeks ago for the prostate treatment to the same private London clinic where his daughter-in-law,  Kate, the Princess of Wales , underwent an unspecified abdominal surgery. She was also  back at home in Windsor and was said to be recovering well  as of Jan. 29.  

Kate's husband, William, the Prince of Wales, who is next in line to inherit the throne after his father, is expected to return to his royal duties this week after taking some time off to support his wife following her surgery, according to Kensington Palace, William and Kate's official residence.

BBC News reported the king personally informed his immediate family, including William, of the diagnosis. Sources confirmed to CBS News on Monday that the king's younger son, Prince Harry, had spoken with his father about his diagnosis, and on Tuesday he arrived back to the U.K. to visit the monarch.

Harry, the Duke of Sussex, moved to the U.S. several years ago with his wife Meghan as they relinquished their roles as senior working members of the royal family.

Sunak said in a social media post on Monday that he was "wishing His Majesty a full and speedy recovery," and that he had no doubt Charles would "be back to full strength in no time."

King Charles III & Queen Camilla attend Sunday Church

President Biden reacted to the news during a campaign trip in Las Vegas, ahead of Nevada's upcoming presidential primary, telling reporters he had just been informed of the British monarch's diagnosis, was "concerned about him," and would "be talking to him, God willing."  

Later on social media, Mr. Biden, whose oldest son Beau Biden died of brain cancer in 2015, said he and first lady Jill Biden were praying for the king's recovery.

"Navigating a cancer diagnosis, treatment, and survivorship takes hope and absolute courage," the president said . "Jill and I join the people of the United Kingdom in praying that His Majesty experiences a swift and full recovery."

Alex Sundby contributed reporting .

  • King Charles III
  • British Royal Family
  • Prostate Cancer
  • King Charles

Tucker Reals is cbsnews.com's foreign editor, based in the CBS News London bureau. He has worked for CBS News since 2006, prior to which he worked for The Associated Press in Washington D.C. and London.

More from CBS News

Royal insider on King Charles' cancer diagnosis and what it means

Back to public duties, Prince William addresses family's health issues

Scalise returning to Washington as another Mayorkas impeachment vote expected

Sebastián Piñera, former Chilean president, dies in helicopter crash

UCL logo

Oncology MPhil/PhD

London, Bloomsbury

When you study an oncology research degree at the UCL Cancer Institute, you join a supportive and intellectually rigorous environment to develop your research skills, subject knowledge, and critical review abilities. Our excellent facilities, supervision and training opportunities prepare students for careers in academia, industry, business, biomedicine, and healthcare.

UK tuition fees (2024/25)

Overseas tuition fees (2024/25), programme starts, applications accepted.

  • Entry requirements

A minimum of an upper second-class UK Bachelor’s degree in a relevant discipline or an overseas qualification of an equivalent standard.

The English language level for this programme is: Level 3

UCL Pre-Master's and Pre-sessional English courses are for international students who are aiming to study for a postgraduate degree at UCL. The courses will develop your academic English and academic skills required to succeed at postgraduate level.

Further information can be found on our English language requirements page.

Equivalent qualifications

Country-specific information, including details of when UCL representatives are visiting your part of the world, can be obtained from the International Students website .

International applicants can find out the equivalent qualification for their country by selecting from the list below. Please note that the equivalency will correspond to the broad UK degree classification stated on this page (e.g. upper second-class). Where a specific overall percentage is required in the UK qualification, the international equivalency will be higher than that stated below. Please contact Graduate Admissions should you require further advice.

*Should you experience any issues with the drop-down below, try de-selecting the country and re-selecting it. If this doesn't work, then you may refer to this page which may help you find the same equivalencies - check the Entry requirements above beforehand. Please note the table is indicative only, revisiting when the dropdown is working to confirm is recommended.

About this degree

Oncology is one of five research departments within the Cancer Institute. We cover areas such as antibody-based medicines, the research and development of cancer drugs, head and neck cancers, treatment resistance, urological cancer biology, cancer metastasis, glioblastoma research, and tumour immunogenomics.

You will develop your research hypothesis with your supervisors, and undertake novel laboratory, bioinformatic or clinical research as part of their research team. You will be supported by a supervisory team including your principal supervisor, and a thesis committee which comprises a secondary supervisor and one to three committee members.

Developing your knowledge and skills is a core priority for us. In addition to UCL ' s Doctoral Skills Programme, the Cancer Institute runs a compulsory first-year training programme to improve your research skills and provide networking opportunities.

This programme is based in London and is available on a full-time or part-time basis.

Who this course is for

We welcome high achieving students from all over the world who want to join a world-class centre to undertake research in oncology. Our students come from a wide range of backgrounds, including clinicians, scientists, bio-informaticians and others interested in oncology research.

What this course will give you

  • A unique opportunity to work in a collaborative research environment that spans basic research, translational medicine, and clinical applications.
  • Close links with associated clinical trials facilities, experimental cancer medicine centre, biobanking facilities and associated partners and hospitals in London such as the Royal Free Hospital, UCLH, and Cancer Research UK and the Crick Institute.
  • Skills development, including bench and technical skills, critical evaluation of scientific literature, experimental planning and design, interpretation of data results, presentation/public speaking skills, time and project management, working within a team, working independently, and writing for various audiences.

The foundation of your career

Our excellent facilities, supervision and training opportunities prepare you for future careers in academia, research companies, industry, business, biomedicine, and healthcare.

Employability

Graduates go on to further medical training or clinical posts, or to academic posts at institutions including universities around the world.

They have also found employment in laboratory management, research, industry, clinical trials co-ordination, scientific writing and editing, sales, and consulting.

The programme is designed to give you networking opportunities throughout your period of study.

These include weekly internal divisional seminars, fortnightly external speaker seminars and reception, and student poster sessions. You will also attend the annual Cancer Institute Conference, as well as national and international research conferences, and academic careers days.

On graduating, you will be able to join the institute's alumni network on LinkedIn.

Teaching and learning

Most of your research will be carried out independently. There will also be a series of training requirements that you will need to complete in the early stages of the programme.

All research students attend a training programme on lab skills from January to July in the first year. This covers:

  • Human Tissue Act and the Biobank
  • Tissue Preparation and Staining
  • Basics of Proteomics
  • Principles of Good Clinical Lab Practice
  • Clinical Trial Design and Regulation
  • In vivo Study Design and Regulation
  • Preclinical Radiotherapy
  • Single Cell Analysis.

Your first milestone will be to upgrade from MPhil to the PhD degree. For this, you will submit and present a report. In your final year, you submit a thesis covering your research and discuss this at a formal interview known as a viva examination.

Most of your time will be spent conducting independent research, alongside regular meetings with your supervisory team and completing your training requirements. We also encourage you to attend relevant research events at UCL and elsewhere.

Research areas and structure

  • Antibody Based Medicines
  • Cancer Drug Development
  • Drug-DNA Interactions
  • Molecular Oncology
  • Tumour Biology on Therapeutic Response

Research environment

UCL is a top-rated university in the UK for research strength in the Research Excellence Framework (REF 2021). Our scientists have an international reputation for leading basic, translational, and clinical cancer research and the Cancer Institute is uniquely positioned to leverage the multidisciplinary nature of UCL by engaging a range of disciplines to transform cancer research.

You will join a community of over 300 research scientists and 120 research students within the Cancer Institute. Our combination of fundamental cancer research, clinical links with UCLH, and the Royal Free Hospitals, and collaborative links with the Crick Institute and Cancer Research UK, make the Cancer Institute an exciting environment for basic and translational research into cancer.

The Department of Oncology has a range of research including:

  • Cancer Research UK Drug-DNA Interactions
  • Cell Signalling
  • Chromosome Instability Research Group
  • HPV Tumour Biology Team
  • Head and Neck Cancers
  • Head and Neck Cancer Biology Group
  • The Cell Communication Lab
  • Treatment Resistance Group
  • Urological Cancer Biology Group
  • Cancer Genome Evolution Research Group
  • Cancer Metastasis Lab
  • Computational Cancer Genomics
  • Glioblastoma Research Group
  • Tumour Immunogenomics and Immunosurveillance Lab

We encourage you to become part of the community and to present and discuss your work at research team meetings, Institute Research in Progress talks, the annual Cancer Institute conference and Research Student poster day. You will also be encouraged to present at relevant international conferences and, where appropriate, to contribute towards scientific publications in your field.

The duration of a full-time research degree is usually three to four years. You register initially for the MPhil degree.

Within three months of joining the programme, you are expected to agree the basic structure of your research project with your supervisor, along with an appropriate research method and a realistic plan of work. You produce and submit a detailed outline of your proposed research to your supervisor and thesis committee for their comments and feedback.

You will then undertake this project as part of your supervisor’s research team. Training workshops at the Cancer Institute will run from January to October.

In your second year, you continue to explore your research hypothesis and collect and analyse novel data. You will also be expected to upgrade from an MPhil to a PhD.

To complete your upgrade, you submit a report summarising your research to date, and present and answer questions about this work at a viva voce examination. You also present your research to the department at a Research in Progress seminar.

In your third year, you complete your data collection and analysis, and prepare your thesis. You will also be encouraged to present your findings at an international conference or annual Cancer Institute conference.

Following the third year, you may be eligible for a year of 'completing research status' to complete your thesis and to take your viva examination.

The duration of a part-time research degree is usually five years. You register initially for the MPhil degree.

Within five months of joining the programme, you are expected to agree the basic structure of your research project with your supervisor, along with an appropriate research method and a realistic plan of your work. You will produce and submit a detailed outline of your proposed research to your supervisor and thesis committee for comments and feedback.

In your second and third years (18-36 months), you will continue to explore your research hypothesis and collect and analyse novel data. You will also be expected to upgrade from an MPhil to a PhD.

To complete your upgrade, you submit a report summarising your research to date, and then present and answer questions about this work at a viva voce examination. You also present your research to the department at a Research in Progress seminar.

In your fourth and fifth years, you complete your data collection and analysis, and prepare your thesis. You will also be encouraged to present your findings at an international conference or annual Cancer Institute conference.

Following the fifth year, you may be eligible to transfer to 'completing research status' for two years to complete your thesis writing and to undertake your viva examination.

Accessibility

Details of the accessibility of UCL buildings can be obtained from AccessAble accessable.co.uk . Further information can also be obtained from the UCL Student Support and Wellbeing team .

Fees and funding

Fees for this course.

The tuition fees shown are for the year indicated above. Fees for subsequent years may increase or otherwise vary. Where the programme is offered on a flexible/modular basis, fees are charged pro-rata to the appropriate full-time Master's fee taken in an academic session. Further information on fee status, fee increases and the fee schedule can be viewed on the UCL Students website: ucl.ac.uk/students/fees .

Additional costs

Students receive a free printing allowance each year and pay for any additional printing ( see details ). You may also face additional expenses if you attend conferences. The cost depends on the location, exchange rates, and the price of travel and accommodation, but this may be between £200 and £500 per event, based on typical events / destinations attended by recent students. The Cancer Institute provides two competitive travel scholarships each year to support research students attending training workshops or international conferences.

If you are doing a wet lab project, there may be an Additional Fee Element (AFE, also known as bench fees). This is an additional annual cost related to consumables, equipment or materials based on your individual project. This is payable by your sponsor, or yourself, if self-funding. These additional costs depend on the project and will be the same for home and overseas students.

The Cancer Institute provides some competitive travel scholarships to support research students attending training workshops or international conferences.

For more information on additional costs for prospective students please go to our estimated cost of essential expenditure at Accommodation and living costs .

Funding your studies

Annual CR-UK funded clinical fellowships and non-clinical PhD studentships are available. Please check the Cancer Institute website for details. Other funded studentships will also be advertised on the Institute's website as they become available. Some of our students seek funding from their home country or cancer charities.

For a comprehensive list of the funding opportunities available at UCL, including funding relevant to your nationality, please visit the Scholarships and Funding website .

Your first steps are to find a supervisor and funding before applying. You should check both the UCL and the Cancer Institute's studentships to apply for specific projects with grants. You can also reach out directly to any potential supervisor, particularly if you have funding in place from another source. You can identify Principal Investigators via the Cancer Institute website and research them individually. If you need help, please see applying for graduate research study or contact the Admissions Tutor on [email protected].

You can apply at any time. However, there are three entry points over the year. Deadlines and start dates are usually dictated by funding arrangements and supervisor availability, so discuss this with your supervisors.

Please note that you may submit applications for a maximum of two graduate programmes (or one application for the Law LLM) in any application cycle.

Choose your programme

Please read the Application Guidance before proceeding with your application.

Year of entry: 2024-2025

Year of entry: 2023-2024, got questions get in touch.

Cancer Institute

Cancer Institute

[email protected]

UCL is regulated by the Office for Students .

Prospective Students Graduate

  • Graduate degrees
  • Taught degrees
  • Taught Degrees
  • Applying for Graduate Taught Study at UCL
  • Research degrees
  • Research Degrees
  • Funded Research Opportunities
  • Doctoral School
  • Funded Doctoral Training Programmes
  • Applying for Graduate Research Study at UCL
  • Teacher training
  • Teacher Training
  • Early Years PGCE programmes
  • Primary PGCE programmes
  • Secondary PGCE programmes
  • Further Education PGCE programme
  • How to apply
  • The IOE approach
  • Teacher training in the heart of London
  • Why choose UCL?
  • Entrepreneurship
  • Inspiring facilities and resources
  • Careers and employability
  • Your global alumni community
  • Your wellbeing
  • Postgraduate Students' Association
  • Your life in London
  • Accommodation

King Charles: Why cancer is an entirely individual disease - and which factors will influence monarch's treatment

The 75-year-old monarch underwent treatment for an enlarged prostate in January. In a statement, Buckingham Palace shared that a "separate issue of concern" was raised during his stay.

phd cancer uk

Science and technology editor @t0mclark3

Monday 5 February 2024 23:23, UK

King Charles III

Given most of us prefer to keep our health matters private, it's absolutely no surprise Buckingham Palace have decided not to reveal more details about the King's cancer diagnosis, other than to say it's not prostate cancer.

There will be speculation of course: about the type of cancer; what treatment might entail; what the prognosis is.

Speculation is always a pointless - but particularly so when it comes to cancer.

It's an entirely individual disease, based on the genetics of the patient involved, the highly variable characteristics of the cancer itself and how widespread it might be in the body.

Treatment options are influenced by all of those factors.

Follow live: Prince Harry to travel to UK to see King

For that reason, even if we were to know what kind of cancer the King has, we'd still be deep in the realms of speculation when it comes to what the impact on his life might be.

More on Cancer

phd cancer uk

King Charles's cancer diagnosis sparks surge in searches for NHS advice on disease

phd cancer uk

Chernobyl's mutant wolves appear to have developed resistance to cancer, study finds

Teaser

King Charles cancer: How long do people wait for treatment, which types are most common for older men and what are the survival rates?

Related Topics:

  • Royal Family

But the fact this cancer was spotted as a result of an unrelated procedure means the King and his doctors were fortunate.

Please use Chrome browser for a more accessible video player

phd cancer uk

For nearly all types of cancer, the earlier it's detected, the greater the chance treatment is successful.

The palace's decision to go public with the diagnosis is likely to have been influenced by recent events.

The public announcement about the King's treatment for an enlarged prostate - a very common, but often not talked about, condition in men as they get older - led to a huge spike in people seeking out information on the condition.

Read more: Buckingham Palace statement in full Prince Harry to travel to UK to see King 'in coming days' PM wishes King 'full and speedy recovery' after cancer diagnosis

phd cancer uk

If we see a similar reaction to this latest announcement, and people are encouraged to put concern to one side and see a doctor about a change in their health that could be due to cancer, it could help undiagnosed cancers get diagnosed earlier.

Click to subscribe to the Sky News Daily wherever you get your podcasts

Let's not forget cancer is very common - around 1000 cases are diagnosed in the UK every day - but survival rates for many types are improving all the time. Overall, cancer survival rates have doubled in the last 50 years.

That of course, can, and should, make it easier to talk about cancer.

Related Topics

IMAGES

  1. PhD study at the Cancer Research UK Cambridge Institute

    phd cancer uk

  2. Funded PhD studentships in cancer research

    phd cancer uk

  3. PhD Studentship in Cancer Biology Imperial Cancer Research UK

    phd cancer uk

  4. London Cancer PhD Student Network

    phd cancer uk

  5. Black Leaders in Cancer PhD Scholarship Program at University of

    phd cancer uk

  6. Science Talk

    phd cancer uk

COMMENTS

  1. PhDs for science graduates

    An integral part of the team Our PhD students are integral to our research. Like all our scientists, you'll benefit from what our dedicated research sites have to offer, including working in a unique multidisciplinary environment and collaborating with cancer researchers and clinicians from The Royal Marsden NHS Foundation Trust.

  2. Cancer Institute MPhil/PhD

    Cancer Institute MPhil/PhD London, Bloomsbury A full or part-time research degree at the UCL Cancer Institute offers an unrivalled foundation for building a career in cancer.

  3. Opportunities for PhD students and postdoc researchers

    We're committed to supporting the next generation of cancer researchers, and our community includes around 550 PhD students and 750 postdoctoral researchers. Our researchers benefit from support including networking groups and events, training, travel grants, and opportunities to begin developing their independent research careers.

  4. DPhil in Cancer Science

    The Cancer Research UK Oxford Centre awards around 15 full-time positions on the DPhil in Cancer Science Programme each year for researchers looking to start their academic career at one of the world's leading research organisations. The programme is unique and distinctive in offering integrated training across the following themes: Immuno-Oncology; Cancer Big Data; Novel Therapeutics; Early ...

  5. Cancer Research UK PhD programme

    The Cancer Research UK PhD programme is integrated into the research activities of the Centre with over 80 principal investigators contributing to this cross-disciplinary programme spanning from fundamental science to translational research.

  6. PhD programmes and cohorts

    Deadline: Monday 06 November 2023 The ICR's MRC-funded Doctoral Training Partnership aims to prepare students to build and execute collaborative multidisciplinary research projects and provide them with the skills and capabilities to translate their innovations for the benefit of patients.

  7. PhD/MPhil Cancer Sciences

    Programme details Careers Degree awarded Doctor of Philosophy Duration 3-4 years PhD, 1-2 years MPhil Entry requirements We require applicants to hold, or be about to obtain, an Upper Second class Honours degree, or the equivalent qualification gained outside the UK, in a related subject area for entry to a PhD programme.

  8. Postgraduate research opportunities A-Z

    Cancer Sciences PhD/iPhD/MSc (Research) The School of Cancer Sciences is a broad-based, research intensive institution with a global reach. We span fundamental cancer biology, translational and clinical cancer research with a major focus on cancer genomics and disease-specific research.

  9. Cancer (Edinburgh Cancer Research Centre) PhD, MScR

    Research profile. Edinburgh Cancer Research UK Centre (ECRC) strives to take a comprehensive approach to cancer research, combining both laboratory-based research and clinical approaches. Overall the centre studies the genetic and biological basis of cancer and disease pathology, and devises and test new forms of therapy arising from our basic ...

  10. Cancer Research UK Manchester Institute PhD Graduate Programme

    Cancer Research UK Manchester Institute PhD Graduate Programme The CRUK Manchester Institute is a leading cancer research institute within the University of Manchester, and is supported by major core funding from Cancer Research UK, the largest independent cancer research organisation in the world.

  11. DPhil in Cancer Science

    About Entry Requirements Resources Department Funding and Costs College preference How to Apply About the course This DPhil programme is for basic science graduates, clinical students and trainee clinicians who want to undertake advanced study in the field of cancer research.

  12. Cancer & Pharmaceutical Sciences

    The School of Cancer and Pharmaceutical Sciences comprises of the Comprehensive Cancer Centre (CCC), Institute of Pharmaceutical Sciences (IPS) and recently incorporated Analytical, Environmental & Forensic Sciences Department. Within the Comprehensive Cancer Centre there are thirteen research programmes and 20 research groups.

  13. Cancer Research UK Cambridge Institute

    The PhD in Medical Science in the Cancer Research UK Cambridge Institute (CRUK CI) is a research course in which each student is integrated into their principal supervisor's team of researchers, working closely with their postgraduate and postdoctoral colleagues. Each student will work on a well-defined, specific project which will be aligned ...

  14. Cancer Research UK Clinical PhDs at the University of Birmingham

    A prestigious Cancer Research UK Clinical Academic Training Programme, led by Professor Gary Middleton, offering fully funded clinical PhD fellowships, aligned with our cancer focused research from the Institute of Cancer & Genomic Sciences, the Institute of Immunology & Immunotherapy and the Institute of Metabolism and Systems Research .

  15. Cancer MPhil, PhD, MD

    Cancer MPhil, PhD, MD. We're a major training base for the next generation of cancer researchers. Clinicians, scientists and students engaged in cancer research at Newcastle share a common purpose: to improve treatment outcomes for patients with cancer. You are currently viewing course information for entry year: 2024-25.

  16. Cancer Biology PhD / MPhil / MD

    Open to international applicants Apply all year round Available as: Full time - Part time A broad range of research interests provides for world-class research in cancer biology, supported by world-class clinical research into several major types of cancer. Why study with us?

  17. PhD in Oncology

    PhD in Oncology Overview Study Requirements Finance How To Apply The PhD course is a three to four years full-time, or five to seven years part-time research-based course. Full-time PhD students are probationary in the first year and progression to the second year (and registration for the PhD) depends on a successful first-year assessment.

  18. Postgraduate Research

    Barts and The London School of Medicine and Dentistry This training programme, part of a multimillion pound award from Cancer Research UK (CRUK), aims to develop a cohort of scientists equipped both intellectually and technically to conduct the highest quality research in cancer.

  19. Programmes

    The Institute is committed to training the scientific leaders of tomorrow. Our MPhil and PhD programmes prepare students for fulfilling careers in academia, industry, or roles outside of the lab. PhD in Medical Science The PhD in Medical Science course at the CRUK CI allows students to become fully embedded within their Principal Supervisor's research team, giving them close interactions ...

  20. Cancer Biology PhD Projects, Programmes & Scholarships in the UK

    We have 242 Cancer Biology PhD Projects, Programmes & Scholarships in the UK A PhD in Cancer Biology would provide you with the opportunity to research a specific cancer in great detail.

  21. Cancer Research UK MB-PhD

    The Cancer Research UK MB-PhD is a fully funded three-year programme aimed at MBChB students wishing to intercalate to train as clinician scientists. This training route will see you work towards both your MBChB and PhD awards over the course of the programme, combining your medical training with research training in the area of cancer sciences

  22. Black Leaders in Cancer PhD Scholarship Programme

    4 years This programme aims to help develop the next generation of Black leaders in cancer research. Eligibility Our programme is aimed at students from Black heritage backgrounds pursuing a PhD in cancer-related fields.

  23. Surge in UK cancer patients going private revealed as King Charles

    UK cancer care in crisis and patients will die due to lack of strategy, experts warn. 15 Nov 2023. AI better than biopsy at assessing some cancers, study finds. 31 Oct 2023.

  24. Procedure for an enlarged prostate led to King Charles' cancer diagnosis

    An enlarged prostate is not linked to cancer, and it is relatively common among older men: Around 80% of men over age 70 have it, according to Yale Medicine. Charles turned 75 in November. Charles ...

  25. Advances in UK cancer survival fall sharply

    The likelihood of surviving cancer for 10 years or more in the UK has improved from 47.9 per cent in 2010-11 to 49.8 per cent in 2018, the analysis commissioned by the charity from the Cancer ...

  26. King Charles III's cancer was "caught early," U.K. Prime Minister Rishi

    The unspecified cancer was discovered as doctors treated the monarch for an enlarged prostate just over a week ago. British Prime Minister Rishi Sunak told CBS News partner network BBC News ...

  27. Oncology MPhil/PhD

    Oncology MPhil/PhD. When you study an oncology research degree at the UCL Cancer Institute, you join a supportive and intellectually rigorous environment to develop your research skills, subject knowledge, and critical review abilities. Our excellent facilities, supervision and training opportunities prepare students for careers in academia ...

  28. King Charles: Why cancer is an entirely individual disease

    Let's not forget cancer is very common - around 1000 cases are diagnosed in the UK every day - but survival rates for many types are improving all the time. Overall, cancer survival rates have ...

  29. King Charles III has cancer and will step back from public duties

    Britain's King Charles III has been diagnosed with cancer and will step back from public-facing duties while he undergoes treatment, Buckingham Palace announced Monday.. The update came after ...